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Glaucoma is a progressive, chronic optic neuropathy and a leading cause of blindness in the United 
States. It is an asymptomatic disease that affects an estimated 2.7 million Americans, of whom 
only half know they have the disease. As glaucoma severity progresses, people often experience 
changes in their abilities to engage in social life situations, have reduced confidence and/or avoid 
situations they once deemed important and pleasurable, and they may alter how they are able to 
accomplish roles and routines they want to or need to do.  
Historically the effects of glaucoma on people’s daily living have been measured in 
research by vision-specific quality of life (VSQoL), a measure of people’s own perceptions of how 
glaucoma affects their health, well-being, and quality of living. In vision rehabilitation, one 
measure of the effect of an ocular disease on people’s abilities to accomplish daily living is 
participation. Participation is involvement in social life situations. Yet little research has focused 
on participation as an outcome measure for people with glaucoma. Therefore, the objective of this 
study was to explore participation in individuals with glaucoma to better understand the 
relationship between severity of vision loss and the degree to which participation was associated 
with glaucoma severity. 
The aims of this study were to: 1) explore the association between participation and 
glaucoma severity, 2) explore the relationship between participation and VSQoL, and 3) compare 
the relationship between participation and VSQoL as each related to glaucoma severity. 
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We performed correlation analyses and found that participation had a fair association with 
glaucoma severity and a moderate association with VSQoL. In multiple regression analyses, 
findings suggested that for individuals who on average had early stage glaucoma, participation and 
VSQoL were each statistically significant, incremental indicators of glaucoma severity after 
controlling for covariates. Exploring the effects of glaucoma on participation will inform our 
understanding of the effects of glaucoma on function and vision-related disability. A unique 
contribution of this research is its focus on participation and the exploration of participation as a 
potential indicator of severity of vision loss for people who may be at risk for disability. 
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1.0  INTRODUCTION 
Loss of vision has a statistically significant association with disability, as indicated through loss 
of personal independence, impaired mobility and falls, depression, transportation challenges, 
difficulties maintaining employment, and placement in long-term care (Campbell & Crews, 2001; 
de Boer et al., 2004; Desrosiers, Wanet-Defalque, et al., 2009; Haymes, Johnston, & Heyes, 2002; 
Jones, Crews, & Danielson, 2010; Lord, 2006). As people’s vision worsens, their psychological 
burden increases along with a fear of blindness and social withdrawal (Chang-Quan et al., 2010; 
Jampel et al., 2007; McDonnall, 2009; Ramulu, Maul, et al., 2012; Skalicky & Goldberg, 2008; 
Stelmack, 2001). Our daily living involves complex, skilled actions guided by vision. Vision drives 
people’s decision making and contributes to anticipating and planning responses, interpreting 
social situations, aiding in information processing, and dictating motor actions (e.g., postural 
control). People with glaucoma are at risk for progressive loss of vision, often unaware of changes 
in their vision in the early stage of the disease. Since those changes are progressive and not abrupt, 
people likely adapt or unknowingly modify how they accomplish daily living. For this research 
study, we explored the association between individuals’ involvement in life situations (i.e., 
participation) and severity of vision loss as a result of glaucoma. 
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1.1 SIGNIFICANCE 
1.1.1 Glaucoma  
Glaucoma is a progressive, chronic optic neuropathy that may result in a functional loss of vision 
(i.e., visual impairment); it is the second leading cause of blindness worldwide and a leading cause 
of blindness in the United States (U.S.; National Eye Institute, n.d.; Quigley & Broman, 2006). 
Glaucoma is typically characterized by increased intraocular pressure, retinal nerve fiber and optic 
nerve damage, and progressive loss of visual fields (Anderson, 2006; Cassin & Rubin, 2006). It is 
usually an asymptomatic disease, referred to as the ‘silent thief of sight.’ Glaucoma affects an 
estimated 2.7 million Americans, a number that is projected to increase to 4.2 million by 2030 
(National Eye Institute, n.d.). Of the estimated 2.7 million Americans who have glaucoma, only 
half know they have the disease (Friedman et al., 2004; National Eye Institute, 2013).  
 People with a familial history of glaucoma are among the most at risk for developing the 
disease. Race and age are statistically significant risk factors, particularly for African Americans 
aged 40 years and older and Hispanics and Mexican Americans aged 60 to 65 years and older. 
Glaucoma is most prevalent in China, India, and Europe (Quigley & Broman, 2006). Additional 
risk factors strongly associated with severity of glaucoma include myopia, hyperopia, 
cardiovascular disease, diabetes, eye injury, and the use of cortisone steroids (Dahl, 2013; 
Schuman, 2008).  
People with glaucoma demonstrate characteristic behavior that is the consequence of both 
changes in vision and of the increased effort to overcome challenges in daily living in order to 
maintain their independence. It is important to recognize that people are typically unaware of 
changes in their vision as the result of glaucoma until later stages in the disease progression, a 
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point at which permanent vision loss has already occurred. We must consider then that some of 
the challenges in daily living for people with undiagnosed or early stage glaucoma may be subtle 
or hidden; people may naturally manage those challenges through adaptation or by using 
compensatory methods. For example, people may successfully accomplish their daily living but 
modify the way they accomplish tasks or how frequently they engage in tasks. They generally do 
not perceive that those modifications indicate any level of difficulty with task accomplishment.  
As reported in the quality of life (QoL) research, driving, mobility, involvement in the 
community (e.g., crossing the road, reading street signs), reading, adjusting to different levels of 
illumination, judging distances, contrast sensitivity, and peripheral vision-dependent tasks were 
affected by glaucoma (Goldberg et al., 2009; Hochberg et al., 2012; Kuyk, Elliott, & Fuhr, 1998; 
Nelson, Aspinall, & O'Brien, 1999; Nelson, Aspinall, Papasouliotis, Worton, & O'Brien, 2003; 
Ramulu, 2009; Ramulu, Maul, et al., 2012; Ramulu, van Landingham, et al., 2012; Spaeth, Walt, 
& Keener, 2006; Turano, Rubin, & Quigley, 1999; Viswanathan et al., 1999). Changes in mobility 
were characterized by slower ambulation and reaction times, impaired perception of motion, and 
bumping into objects located in the periphery (Kuyk et al., 1998; Turano et al., 1999; Viswanathan 
et al., 1999). Because of these changes in behavior, people had reduced confidence in their abilities 
which led to avoidance of those situations they deemed important and pleasurable (Gilhotra, 
Mitchell, Ivers, & Cumming, 2001; Hartmann & Rhee, 2006; McGwin et al., 2004).  
The least difficult tasks people with glaucoma felt able to manage were looking after their 
appearances and visiting family and friends. The most important tasks (for which they had 
difficulty) were near vision tasks and mobility outside the home while the least important were 
bumping into objects, the impact of glare, and performing household chores. Considering 
involvement in the life situations (i.e., participation) that were the most difficult to manage, people 
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with glaucoma were generally more independent with basic self-care activities, such as grooming, 
and were more dependent with complex instrumental activities of daily living, for example 
community mobility (Hochberg et al., 2012). This is likely because basic self-care management 
over time becomes a rote activity that does not require extensive visual skill. Of note, people with 
severe glaucoma attached greater importance to the integrity of their central vision in the advanced 
stages of the disease than they did in the early stages of the disease (Spaeth et al., 2006). This 
reflects the physiological progression of the disease; the central visual field is generally not 
compromised until the advanced stages. 
1.1.1.1 Visual Sensory Perception  The functional limitations common for people with 
glaucoma directly relate to sensory perception. Glaucoma preferentially affects rod dominated 
areas of the retina resulting in peripheral visual field defects, often sparing the central visual field 
until late stages of the disease. When there is structural impairment to the retina and/or optic 
nerve, information is not sent along the visual pathway for cortical processing. It is estimated that 
up to 50% of retinal ganglion cells are damaged or permanently lost before current diagnostic 
techniques detect structural damage to the retina (Anderson, 2006; Bullimore, Wood, & Swenson, 
1993; Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert 
Committee, 2009). The lost ability to process visual input at the level of the retina disrupts cortical 
sensory perception of motion and thus peripheral awareness (Wolfe et al., 2012). Peripheral vision 
is linked to the cortical processing of spatial information that relates to posture, balance, and 
stability during motion.  
 Motion perception is a mechanism for judging self-motion, reaction responses, postural 
control, and navigation in the environment (Bullimore et al., 1993; Karwatsky, Bertone, Overbury, 
& Faubert, 2006; Shabana, Pérès, Carkeet, & Chew, 2003; Wu, Coffey, Reidy, & Wormald, 1998). 
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People with glaucoma demonstrated higher motion thresholds to detect items in the peripheral 
environment than did people with normal vision (McKendrick, Badcock, & Morgan, 2005). This 
finding suggested that people with glaucoma may have greater difficulty processing complex 
visual tasks (e.g., navigation) than could be predicted merely from their visual field loss. It is 
typically at the moderate or severe stages of glaucoma when people begin to perceive peripheral 
vision loss. Therefore, changes in behavior that may occur in the early stage of the disease could 
be the consequence of loss of visual sensory information. 
1.1.1.2 Medical Evaluation and Interventions for People with Glaucoma  The current 
medical management of glaucoma focuses on maintaining the integrity of eye function and 
structure through early diagnosis and treatment of the signs of the disease to prevent vision loss. 
Common objective clinical measures of vision for people with glaucoma are intraocular pressure, 
visual acuity, visual field, thickness of the retinal nerve fiber layer, and contrast sensitivity (see 
Table 1; Black, Wood, & Lovie-Kitchin, 2011; Jampel et al., 2002; Kulkarni, Mayer, Lorenzana, 
Myers, & Spaeth, 2012; Lamoureux et al., 2007; Ramulu, Maul, et al., 2012; Ramulu, van 
Landingham et al., 2012; Richman et al., 2010; Viswanathan et al., 1999). 
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Table 1. Clinical Measures of Vision for the Medical Evaluation for Glaucoma 
Vision term  Definition Measure 
Contrast sensitivity The ability to detect detail having subtle 
gradations in luminance or color between a 
target and its background 
 
Pelli-Robson contrast 
sensitivity chart 
Intraocular pressure The fluid pressure inside the eye 
 
Tonometry  
Retinal nerve fiber 
layer 
The layer of retinal ganglion cells of the retina 
that receive visual information from 
photoreceptors 
 
Optic coherence 
tomography 
Visual acuity The ability to distinguish detail and shape 
clearly 
Early Treatment Diabetic 
Retinopathy Study 
(ETDRS) acuity charts or 
Snellen charts 
 
Visual field The extent of the area people are able to see 
when the eye is fixated straight ahead  
Automated perimetry 
Note. Optical coherence tomography is a high resolution imaging technique used to take cross-sectional 
images of the thickness of the retina to measure the structural neural integrity of the retinal nerve fiber 
layer and other layers of the retina. 
 
The severity of visual field loss is the benchmark measure for quantifying the severity of 
glaucoma. The emphasis on visual field is related to the neural mechanisms underlying visual 
sensory perception and the preferential loss of peripheral vision. Optical coherence tomography is 
used clinically to measure the thickness of the retinal nerve fiber layer and the vertical cup/disc 
ratio, a measure of the pathological cupping of the optic disc as a result of glaucoma. These 
measures, retinal nerve fiber layer thickness and vertical cup/disc ratio, are also used in addition 
to visual field to classify severity of glaucoma. Physicians and researchers may categorize people 
along a continuum of disease severity based on the degree of visual field loss described by a staging 
system (See Table 2; Mills et al., 2006). 
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Table 2. Exemplars for Staging Severity of Glaucoma 
Stage of glaucoma Mean deviation 
Humphrey Visual Field  
Stage 0 – Ocular hypertension/earliest glaucoma > 0.00 
Stage 1 – Early glaucoma -0.01 to -5.00 
Stage 2 – Moderate glaucoma -5.01 to -12.00 
Stage 3 – Advanced glaucoma -12.01 to -20.00 
Stage 4 – Severe glaucoma ≤ -20.01 
Stage 5 – End stage glaucoma No Humphrey Visual Field (worse-seeing 
eye) 
Octopus Visual Field  
Stage 0 – Ocular hypertension/earliest glaucoma ≤ -0.80 
Stage 1 – Early glaucoma -0.70 to 4.40 
Stage 2 – Moderate glaucoma 4.50 to 9.50 
Stage 3 – Advanced glaucoma 9.50 to 15.30 
Stage 4 – Severe glaucoma 15.40 to 23.10 
Stage 5 – End stage glaucoma ≥ 23.20 
American Glaucoma Society  
Mild No measurable visual field loss but evidence of pathology on clinical 
examination OR optical coherence tomography 
Moderate One hemifield with visual field loss in one or both eyes, not within 10˚ 
of fixation 
Severe Both hemifields with visual field loss in one or both eyes OR involving 
the central 10˚ of visual field in either eye 
Note. From Mills et al. (2006) and physician report.  
 
The medical interventions for glaucoma include: eye drops to control intraocular pressure, 
oral medication (in lieu of or in conjunction with eye drops) to control intraocular pressure, laser 
trabeculoplasty to improve the eye’s drainage system for the flow of aqueous fluid, laser iridotomy 
to create an opening through the iris to manage aqueous fluid flow, trabeculectomy in which a 
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passage is created in the sclera to drain excessive eye fluid, implantation of glaucoma drainage 
device, and cyclodestructive surgery which is a laser to destroy parts of the ciliary body. Potential 
side effects of commonly prescribed medications include eye discomfort such as burning, stinging, 
tearing, and dry/itchiness (Lee et al., 1998; Lopez, Karaca, Ekici, Waisbourd, & Spaeth, 2014). 
Additional side effects of medication may include blurred vision, headaches, and shortness of 
breath. Potential side effects from laser or surgical procedures include infection, blurred vision, 
fluctuating eye pressure, and pain. These laser or surgical-related symptoms are generally short 
term, enduring through the post-operative recovery phase. Eye procedures do not guarantee people 
will no longer require the use of oral or topical medications. 
1.1.1.3 Vision Rehabilitation Evaluation and Interventions for People with Glaucoma  
A goal of vision rehabilitation is for individuals to learn to maximize the use of their remaining 
vision (i.e., usable vision) to develop and/or optimize their abilities to live as independently as 
possible to engage in their roles and routines. Occupational therapists are trained in evaluating 
and treating the interaction between individuals and their environments, contexts and occupations, 
and how those interactions influence individuals’ abilities for independence and maintaining 
function. Direct outcomes evaluated in vision rehabilitation are measured most often by 
individuals’ abilities to execute a task or action (i.e., activity) and to accomplish a life situation 
(i.e., participation). Given what is known about the effects of glaucoma on function and disability, 
that people are generally more independent with basic self-care and more dependent with complex 
and dynamic tasks (Hochberg et al., 2012), it is at the level of participation that we should evaluate 
people who are at risk for or diagnosed with glaucoma.  
The American Occupational Therapy Association recently published practice guidelines 
for working with older adults with low vision (Kaldenberg & Smallfield, 2013). The guidelines 
9 
summarize the common intervention approaches used by occupational therapists with people with 
visual impairment and the scientific evidence that supports the interventions. The intervention 
approaches commonly used with people with glaucoma include sensory substitution, organization 
and environmental adaptation, driving and community mobility, visual skills training, problem 
solving and self-management, and advocacy (see Table 3). Refer to Livengood (2014) for a review 
of the role of occupational therapy in vision rehabilitation for people with glaucoma.  
 
Table 3. Vision Rehabilitation Intervention Approaches Common for People with Glaucoma 
Intervention approach Description Example 
Sensory substitution Use of alternate senses to 
compensate for vision loss 
Use of hearing via a smartphone 
application where the smartphone takes 
a picture of an object and speaks what 
object is in the picture 
   
Organization and 
environmental 
adaptation 
Use of techniques to systematically 
modify and/or arrange items in an 
orderly fashion; increase lighting 
and contrast within the 
environment 
Optimize ambient lighting (proper 
illumination) to reduce shadows in the 
home environment for safe mobility 
   
Driving and 
community mobility 
Alternative driving/transportation 
techniques; safety with community 
mobility 
Education on driving cessation and 
other alternative transportation options 
(including accessibility) 
   
Visual skills training Use of techniques to maximize 
awareness of visual field 
Visual scanning strategies to increase 
awareness of the environment (e.g., 
purposefully turning the head side-to-
side to increase field of view) 
   
Problem solving and 
self-management 
Techniques to facilitate 
participation in daily living  
Facilitate the process of working 
through details of a problem to reach a 
solution 
   
Advocacy Identify support networks (e.g., 
education, community resources, 
referral to appropriate services) to 
optimize function and participation 
Education on the short- and long-term 
implications of glaucoma on 
participation; how to access community 
resources to support independence and 
safety 
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1.1.2 Societal and Individual Burden of Vision Loss 
Understanding glaucoma and its effect on people’s daily living, we can consider the significance 
of the overall burden of vision loss. An estimated 285 million people worldwide have a visual 
impairment that results from limitations of the eye and/or visual system; more than 80% of those 
visual impairments are moderate to severe (World Health Organization [WHO], 2014). Currently, 
there are approximately 3.4 million people in the U.S. aged 40 years and older who are blind or 
have a visual impairment (Friedman et al., 2004). Americans aged 80 years and older were 
members of the fastest growing segment of the population between 2000 and 2010 (Werner, 2011) 
and had the highest rates of visual impairment (Chou et al., 2013). Several factors associated with 
visual impairment include age, gender, race/ethnicity, socioeconomic status, duration of visual 
impairment, location of visual field loss, and multiple comorbidities (Rubin et al., 1997; Schuman, 
2008; Ulldemolins, Lansingh, Valencia, Carter, & Eckert, 2012). 
With increasing age, the prevalence of visual impairment increases and is most dramatic 
after age 75; 1 in 6 people aged 70 years and older has a visual impairment (Dillon, Gu, Hoffman, 
& Ko, 2010). Visual impairment is more prevalent in women. People of particular ethnicities have 
a higher risk of certain types of eye diseases; age-related macular degeneration is more prevalent 
among Caucasians while glaucoma is more prevalent among African Americans.  
There is a link between socioeconomic status and visual impairment, but the underlying 
mechanism has not been determined. Suggested determinants of visual impairment associated with 
socioeconomic status are people’s access to health and eye care and their level of education. 
Reasons people do not seek out eye-care services include cost, lack of insurance, and the 
perception they have nothing wrong with their vision that requires examination (Chou, Sherrod, & 
Zhang, 2011; Centers for Disease Control, 2011; Saaddine et al., 2008). Given these reasons that 
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people do not seek out eye-care services, less than half of people who are eligible for eye 
examinations access vision services. Approximately 40% of working-aged adults have no vision 
insurance and 30% have no vision insurance when they have general health insurance (Li, 
Xirasagar, Pumkam, Krishnaswamy, & Bennett, 2013). Those who have vision insurance are twice 
as likely to receive eye care in the past 12 months (Li et al., 2013).  
Another factor associated with visual impairment is the location of visual field loss. The 
location of visual field loss and specific patterns of vision loss vary depending on the type and 
progression of the eye disease and can differentially affect people’s abilities to accomplish tasks 
associated with daily living (Eichenbaum, 2012; Kotecha, O'Leary, Melmoth, Grant, & Crabb, 
2009; Merigan & Maunsell, 1993; Milner & Goodale, 1995; Patino et al., 2010). Loss of inferior 
visual fields is associated with increased postural sway to a greater extent than loss of superior 
visual fields (Black et al., 2011) and adults with central and/or inferior visual field loss have poorer 
mobility (Lovie-Kitchin, Mainstone, Robinson, & Brown, 1990; Turano et al., 2004). Inferior 
visual field loss is a predictor of lower independence. Similarly, the challenges in managing daily 
living for people with peripheral visual field loss (e.g., glaucoma) are likely to be different from 
those challenges for people with central visual field loss (e.g., age-related macular degeneration; 
(Eichenbaum, 2012; Kotecha et al., 2009; Merigan & Maunsell, 1993; Milner & Goodale, 1995; 
Patino et al., 2010).  
Comorbidities common among people aged 65 years and older who report vision loss 
include: breathing problems, depression, emotional distress, diabetes, heart problems, hearing 
impairment, hypertension, joint problems, low back pain, and stroke (Cardol et al., 2002; Crews, 
Jones, & Kim, 2006; Desrosiers et al., 2006; Lamoureux, Hassell, & Keeffe, 2004; Werner, 2011). 
Each of these conditions is associated with poorer quality of life outcomes and influences people’s 
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abilities to accomplish their typical roles and routines. Dual sensory loss, such as visual 
impairment combined with hearing impairment, leads to a greater perceived visual impairment and 
diminished participation in daily living (Crews et al., 2006; Lin et al., 2004).  
Visual impairment is among the top 10 disabilities among adults aged 18 years and older 
and is among the most common chronic conditions that contribute to people aged 70 years and 
older requiring assistance in daily living activities (Warnecke, 2003). The population of older 
Americans continues to grow, with older adults at greatest risk of experiencing a disability as the 
result of visual impairment. The combination of visual impairment with other co-existing 
conditions may exacerbate the effect of vision loss more than any one condition alone (Crews et 
al., 2006; Horowitz, Reinhardt, & Kennedy, 2005; Jones, Rovner, Crews, & Danielson, 2009; 
Leske et al., 2001; Mukesh, McCarty, Rait, & Taylor, 2002; Schuman, 2008). Disability related to 
visual impairment accounted for approximately 18.8% of the total disabled in 2013 (Institute on 
Disability, 2014). Of the working-aged adults with a visual impairment, approximately 34.7% are 
employed (Brault, 2010). 
1.1.3 Economic Burden of Vision Loss 
Among Americans aged 40 years and older, the annual federal total direct cost of blind and vision 
disorders is an estimated $13.7 billion (Prevent Blindness America, 2007). An additional annual 
$16 billion financial burden is estimated on individual, caregiver, and non-governmental 
healthcare payers (Frick, Gower, Kempen, & Wolff, 2007). The U.S. healthcare expenditure for 
glaucoma is approximately $2.9 billion annually (Fiscella, Lee, Davis, & Walt, 2009; Rein et al., 
2006). For Medicare beneficiaries aged 65 years and older, the medical costs for an event directly 
related to vision loss are approximately 90% non-eye related medical care (e.g., a hip fracture from 
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a fall that was related to poor vision; Javitt, Zhou, & Willke, 2007); the estimated cost of glaucoma 
care is $748 million (Quigley et al., 2013). Recognizing the burdens associated with vision loss, 
initiatives such as Healthy People 2020 have called for evidence-based evaluations and 
interventions to preserve sight and prevent blindness through early detection and timely treatment 
of eye diseases, including vision rehabilitation services (U.S. Department of Health and Human 
Services, 2014). An informed awareness of the consequences of vision loss on daily living and 
disability and its burden on society will direct public health policy to promote education and 
research to improve access to preventative care, evaluation, and interventions. 
1.2 SUMMARY  
The effect of glaucoma on people’s daily living has justifiably received increased attention in 
regard to increasing public health awareness of glaucoma. As the Baby Boomer generation ages, 
the percentage of the total population aged 65 years and older will increase as will the prevalence 
of age-related eye diseases such as glaucoma. The majority of the people with ocular diseases will 
have secondary chronic conditions that also affect their occupational performance. Decreased 
independence related to vision loss can result in a number of disabling consequences, including 
increased likelihood of falls and automobile accidents (Coleman et al., 2004; Haymes, LeBlanc, 
Nicolela, Chiasson, & Chauhan, 2007; Hu, Trumble, Foley, Eberhard, & Wallace, 1998; 
Lamoureux et al., 2008; McGwin et al., 2005; Owsley, McGwin Jr, & Ball, 1998), decreased 
ability to manage daily living (Freeman, Munoz, West, Jampel, & Friedman, 2008; Jones et al., 
2009; Nelson et al., 2003; Parrish et al., 1997; Ramulu, West, Munoz, Jampel, & Friedman, 2009; 
West et al., 2002), and avoidance of or social withdrawal from life situations once deemed 
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important and/or pleasurable (Gilhotra et al., 2001; Hartmann & Rhee, 2006). Factors such as 
general health, socio-economics, mood, and coping strategies also influence how an ocular 
condition affects people’s daily living (Rovner, Casten, Hegel, & Tasman, 2006; Warrian, Spaeth, 
Lankaranian, Lopes, & Steinmann, 2009).  
People who lose vision because of glaucoma may attempt to conceal it or, given the 
asymptomatic progression of the disease that generally is not abrupt, they may not be aware of 
subtle changes in their vision. They may naturally adapt over time to the gradual, progressive 
changes in their vision. For example, they might change how frequently they do a task or use some 
type of compensatory strategy. Vision loss is often a hidden disability, more often overlooked 
during healthcare evaluations than physical impairments. Behavior that results because of vision 
loss may be attributed to other client factors, particularly when behavioral adaptations due to 
changing vision are not intuitive based on standard vision evaluations. Thus, healthcare providers, 
and rehabilitation specialists in particular, need to be aware of what may be subtle signs of behavior 
associated with visual impairment versus physical impairment. The healthcare attitude towards 
people with glaucoma is transitioning from reactive to proactive in regard to identifying people at 
risk for disability (Fried, Herdman, Kuhn, Rubin, & Turano, 1991; Higgins, Janelle, & Manini, 
2013; West et al., 2005).  
The need to better understand the consequences of glaucoma on disability is imperative to 
public health initiatives. Physicians and vision specialists increasingly acknowledge that research 
on how glaucoma affects people’s daily living is as important as research on its effects on the 
structural integrity of the eye. The U.S. Department of Health and Human Services has fronted 
several programs directly related to vision health. The Centers for Disease Control created the 
Vision Health Initiative to provide guidance in the promotion of vision health, to enhance public 
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health surveillance of visual impairment and eye health in the U.S. (Centers for Disease Control, 
2011). Healthy People 2020 strategic plans include programs for prevention, early detection, 
treatment, and vision rehabilitation. Recognizing the effect of glaucoma on people’s daily living 
is an important component of the broader healthcare process for healthcare providers, particularly 
when people with glaucoma receive services for a condition other than vision (e.g., joint 
replacement). With many types of vision loss, people must learn to cope with the fact that their 
vision loss is likely permanent and adapt to how changes in vision affect their daily living. Vision 
science and rehabilitation researchers and clinicians are important in this realm, to help people 
learn to cope with and adapt to their changes in vision, given their expertise in the evaluation of 
human behavior and task analysis. 
As glaucoma can negatively affect people’s daily living and research priorities include 
identifying indicators of the early stage of the disease process for earlier diagnosis and 
intervention, we designed this research study to look at the association between people’s 
involvement in life situations (i.e., participation) and severity of vision loss due to glaucoma. The 
physical detection (medical perspective) and conscious recognition (individual perspective) of 
vision loss as a result of glaucoma occur at a point in the disease process at which permanent vision 
loss has already begun. The more advanced the disease process when glaucoma is detected, the 
more likely there is irreversible vision loss. People are often unaware of subtle changes to their 
vision and the consequences of those changes in the early stage of glaucoma because of the 
asymptomatic progression of the disease. Earlier detection could allow earlier initiation of care. 
For example, early medical treatment can slow or prevent continuing visual field loss by lowering 
intraocular pressure (Adatia & Damji, 2005; Advanced Glaucoma Intervention Study 
Investigators, 1998; Glacuoma Laser Trial Research Group, 1995; Heijl et al., 2002; Lichter et al., 
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2001; Miglior et al., 2005; Yumori & Cadogan, 2011; Zhao, Jia, Sui, & Ellwein, 1998). Changes 
in participation may eventually be used to identify those at an early stage of glaucoma due to the 
consequences of vision loss. However, first we need to establish that participation is independently 
associated with glaucoma severity.  
Historically, research measured the effects of glaucoma on people’s daily living using QoL 
(i.e., people’s perceptions of their well-being; Goldberg et al., 2009; Hochberg et al., 2012; Kuyk 
et al., 1998; Nelson et al., 1999; Nelson et al., 2003; Ramulu, Maul, et al., 2012; Ramulu, van 
Landingham, et al., 2012; Turano et al., 1999; Viswanathan et al., 1999). Changes in behavior and 
diminished QoL were associated with the disease progression of glaucoma. In vision rehabilitation, 
one measure of the effect of glaucoma on people’s abilities to accomplish daily living situations is 
participation. Yet, little research has specifically focused on measuring participation as a direct 
outcome for people with glaucoma. In this research study, we explored the concept of participation 
because it is the immediate focus for vision rehabilitation evaluation and intervention. We contend 
that QoL (WHO Quality of Life Group, 1993; WHO, 2001) and participation (Fougeyrollas, 
Cloutier, Bergeron, Cote, & St-Michel, 1999; WHO, 2001) are two conceptually separate 
constructs and each contributes uniquely to our understanding of the effect of glaucoma on daily 
living. Yet, the distinction between QoL and participation as measures of the effect of glaucoma 
is ambiguous in vision research. Of the little research that studied participation in people with a 
visual impairment, most research studied participation as the dependent variable and found that 
factors such as impaired cognition, impaired physical ability, and medical comorbidities were 
indicators or predictors of participation. In this research study, however, we were interested in 
whether or not participation was an indicator (i.e., independent variable) of severity of glaucoma. 
While there is little research about participation of people with glaucoma, we know that because 
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of the effect of vision loss on visual sensory perception, the consequence of early stage vision loss 
on daily living may not align with clinical measures of visual impairment. 
1.3 PURPOSE OF STUDY 
The objective of this research study was to explore participation to better understand its 
relationship with severity of vision loss related to glaucoma. In this study, participation referred to 
the frequency of participation, participation accomplishment, and satisfaction with participation. 
1.3.1 Aim 1: Explore the Association between Participation and Severity of Glaucoma 
The primary aim of this study was to explore the association between participation (frequency, 
accomplishment, and satisfaction) and severity of glaucoma. We hypothesized that participation 
would have at least a moderate association with severity of glaucoma (i.e., lower participation for 
people with worse severity of glaucoma) after controlling for covariates.  
1.3.2 Aim 2: Explore the Relationship between Participation and Vision-Specific Quality 
of Life 
The second aim of this study was to explore whether there was a relationship between participation 
and vision-specific quality of life (VSQoL). We hypothesized that participation would have a 
positive correlation (rho ≥ .40) with VSQoL.  
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1.3.3 Aim 3: Compare the Relationship between Participation and Vision-Specific Quality 
of Life as They Each Related to Severity of Glaucoma 
The third aim of this study was to compare the association between participation and severity of 
glaucoma to the association between VSQoL and severity of glaucoma to explore whether 
participation had a more robust association with severity of glaucoma. We hypothesized that 
participation would have a stronger association with severity of glaucoma than VSQoL. 
19 
2.0  QUALITY OF LIFE AND PARTICIPATION IN VISION RESEARCH 
Over the past several decades, healthcare has influenced outcomes research. Specifically, the 
introduction of patient-reported outcomes (Glickman & Peterson, 2009) were integrated as 
primary measures in vision research. Patient-reported outcomes measure whether or not services 
provided by healthcare providers improved patients’ health and well-being, as perceived by the 
patients themselves. Patient-reported outcomes are any statement or measure of health reported by 
a patient, without any interpretation given by a clinician or researcher, to quantify people’s 
perceptions of their health (Denniston, Kyte, Calvert, & Burr, 2014; Meadows, 2011). Patient-
reported outcomes are used to assess performance and to determine the comparative effectiveness 
of interventions, linking reimbursement to the evidence of the effectiveness of interventions.  
Historically, quality of life (QoL) has been the most common patient-reported outcome 
measure of health, in regard to function and disability, used by both healthcare providers and vision 
researchers. However, QoL is a multidimensional construct. As such, it may not be fully sensitive 
to the effects of disease on specific aspects of function and disability, specifically with regard to 
identifying areas of people’s daily living most affected by a disease or health condition. In vision 
rehabilitation, participation is a measure of function and disability specific to people’s involvement 
in life situations. Despite the fact that participation is one measure used in vison rehabilitation, 
distinct measures of participation have not been integrated into research until recently. While it 
appears there are conceptual similarities and differences between QoL and participation, 
variability in definitions, applications, and interpretations of each contribute to ambiguity in the 
vision science literature. Arguably, participation is one component included within the broader 
conceptualization of QoL. 
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The purpose of this chapter is to describe the state of the science in regard to the 
conceptualization of QoL and participation in vison research, specifically in regard to glaucoma. 
We describe a theoretical framework to characterize glaucoma and its association with function 
and disability and apply the framework to current evaluation methods for both medical 
management and vision rehabilitation of people with glaucoma. 
2.1 THEORETICAL FRAMEWORK 
Two common theoretical frameworks used in vision science and rehabilitation research are the 
Disability Creation Process (DCP; Fougeyrollas et al., 1998) and the International Classification 
of Functioning, Disability and Health (ICF; Leissner, Coenen, Froehlich, Loyola, & Cieza, 2014; 
World Health Organization [WHO], 2001). In 1980 the WHO published the International 
Classification of Impairments, Disabilities and Handicaps (ICIDH) to conceptualize between 
biological, functional, and social consequences of trauma and disease (WHO, 1980). The DCP 
originated from the Quebec Committee on the ICIDH and was a revision based on the ICIDH 
(Fougeyrollas, Cloutier, Bergeron, Cote, & St-Michel, 1999). The DCP model is based on the 
interaction between individuals (i.e., personal factors) and their environment (see Figure 1A). The 
ICF was the direct revision of the ICIDH adopted by the WHO and was developed from a 
biopsychosocial perspective, which recognizes the interaction between physical, psychological, 
and social factors on health (WHO, 2001). This perspective also recognizes the importance of 
people’s perceptions of their health and well-being.  
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A. 
 
B. 
Figure 1. Theoretical frameworks used in vision research. (A) Disability Creation Process 
(Fougeyrollas & Noreau, 2003) and (B) International Classification of Functioning, Disability 
and Health (World Health Organization, 2001). 
 
The most common theoretical framework used in the United States is the ICF. The ICF is 
a model intended to provide a globally accepted, standard language and framework to describe 
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health as an interactive process between health conditions and contextual factors mediated by three 
components of function and disability: 1) body functions and body structures, 2) activities, and 3) 
participation (see Figure 1B). Body functions are the physiological functions of body systems and 
body structures are the anatomical parts of the body such as organs. Activity is the execution of a 
task or action by an individual. Participation is the involvement in a life situation. In this 
framework, function is an overarching term that encompasses all body functions and structures, 
activities, and participation. Disability is an overarching term for any problems in body functions 
or body structures (impairments); difficulties people experience in the execution of a task or action 
(activity limitations); and difficulties in the involvement of a life situation (participation 
restrictions). For example, glaucoma is a health condition that often presents with visual field loss 
(impairment) that may affect an individual’s ability to drive (activity limitation) which in turn may 
affect successful employment (participation restriction). To better understand the distinction 
between QoL and participation for this study, we review the two constructs according to the ICF. 
For this research study, we used the ICF as the theoretical framework to specify the 
constructs of QoL and participation. The objective of this study was to explore participation in 
individuals with glaucoma to better understand its association with severity of glaucoma. We 
designed the study to include QoL even though our primary focus was on participation. We 
included QoL as a comparison variable to participation because (1) QoL is a measure so often used 
in vision research and its interpretation is familiar to researchers and clinicians and (2) we contend 
there are conceptual distinctions between the two outcomes. Participation has been used less 
frequently in vision research so its measurement may be less understood. Therefore, the two 
constructs that were of greatest importance in this study were QoL and participation. 
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2.1.1 Quality of Life: Conceptual Definition 
Over the past 15 years, in addition to reports of medical advancements in glaucoma care, glaucoma 
research has steadily yielded more published articles to describe the lived experiences of people 
with glaucoma. The most common primary outcome measured was the effect of glaucoma on QoL, 
more specifically the effect of glaucoma on vision-specific quality of life (VSQoL). Within 
research and clinical practice QoL is an overall global measure of people’s perceived quality of 
their daily life (i.e., well-being). In this study, we refer to QoL from the perspective of VSQoL, 
which refers to the effect of ocular conditions and changes in function related to vision on people’s 
health and well-being.  
The WHO Quality of Life Group (1993) defined QoL as individuals’ perceptions of the 
quality of their life in the context of the culture and value system in which they live. Simply stated, 
QoL is an individual’s subjective well-being (WHO, 2001). It is an important distinction to note 
that QoL is multidimensional in that it measures several areas of life domains: physical health, 
psychological health, level of independence, social relationships, the environment, and personal 
beliefs (see Figure 2). Because QoL is a multidimensional construct that conceptually encompasses 
multiple domains in the ICF framework, it is not directly represented in the ICF model as a single 
domain (see Figure 1B). There are multiple conceptual models of QoL and the definitions and 
measurement of QoL in research have been elusive (Moons, Budts, & De Geest, 2006). The 
discrepancies in the definitions, applications, and interpretations of QoL make it an ambiguous 
concept. The lack of conceptual clarity also results in operational disparities for instrument design 
and outcome measurement. The validity of an instrument is compromised when the underlying 
construct for which it is designed to measure is not well specified. In this study, we defined QoL 
as conceptualized by the ICF and WHO. 
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Figure 2. Conceptual Representation of Quality of Life published by the World Health Organization 
Quality of Life Group (World Health Organaization Quality of Life Group, 1993). 
 
2.1.1.1 Vision-Specific Quality of Life: Measurement  Understanding how QoL is 
conceptualized, we can better understand how it is measured. Over the past decade, there was a 
paradigm shift in outcome measurement focused on QoL (Carr, Gibson, & Robinson, 2001); 
researchers in vision rehabilitation developed instruments and studied how to best measure 
VSQoL. VSQoL instruments are primarily self-report questionnaires by which respondents are 
typically asked to rate their perceived level of difficulty to complete specific tasks. In addition to 
rating the level of difficulty to complete a task, respondents may also be asked to indicate the 
importance of completing such tasks. 
There are numerous QoL and VSQoL questionnaires available and used in glaucoma 
research which vary in their emphasis; for example, health-related QoL versus glaucoma-specific 
QoL. Several of the most common questionnaires used in glaucoma research are the Medical 
Outcomes Study Short Form Health Survey-36, Glaucoma Quality of Life-15, Impact of Vision 
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Impairment, and National Eye Institute Visual Function Questionaire-25 (see Table 4; Hamzah, 
Burr, Ramsay, Azuara-Blanco, & Prior, 2011; Severn, Fraser, Finch, & May, 2008; Spaeth, Walt, 
& Keener., 2006; Vandenbroeck, De Geest, Zeyen, Stalmans, & Dobbels, 2011).  
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Table 4. Quality of Life and Vision-Specific Quality of Life Instruments used with 
People who have Glaucoma 
Instrument  Number of items Domains 
SF-36 36 Physical function 
  Bodily pain 
  Role limitations 
  Emotional well-being 
  Social function 
  Energy/fatigue 
  General health 
 
GQL-15 15 Near vision 
  Peripheral vision 
  Outdoor mobility 
  Dark adaptation 
 
IVI 32 Leisure and work 
  Consumer and social interaction 
  Household and personal care 
  Mobility 
  Emotional reaction to vision loss 
 
VFQ-25 25 General health 
  General vision 
  Ocular pain  
  Near vision  
  Distant vision  
  Vision-specific social functioning 
  Vision-specific role difficulties 
  Vision-specific mental health 
  Vision-specific dependency 
  Driving  
  Peripheral vision  
  Color vision  
Note. SF-36 = Medical Outcomes Study Short Form Health Survey-36; GQL-15 = 
Glaucoma Quality of Life-15; IVI = Impact of Vision Impairment; VFQ-25 = Visual 
Function Questionnaire-25. 
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The Medical Outcomes Study Short Form Health Survey-36 is an example of a health-
related QoL instrument. It is a reliable and validated 36-item instrument that demonstrated 
discriminate validity between people with and without glaucoma (Wilson et al., 1998). However, 
it has correlated weakly to measures of visual impairment such as visual field and visual acuity 
(Parrish et al., 1997). The Medical Outcomes Study Short Form Health Survey-36 was mostly used 
prior to the emergence of VSQoL instruments. The Glaucoma Quality of Life-15 questionnaire is 
an example of a glaucoma-specific instrument (Nelson, Aspinall, Papasouliotis, Worton, & 
O’Brien, 2003). It is a reliable and validated 15-item instrument. However, it only queries activity 
limitations and focuses on the physical effects of the disease process (Khadka et al., 2013).  
The Impact of Vision Impairment questionnaire is one example of a VSQoL instrument 
(Weih, Hassell, & Keeffe, 2002). It is a reliable and validated 32-item instrument; however, when 
evaluated using Rasch analysis the instrument had poor targeting (Lamoureux et al., 2007). Poor 
targeting suggested the items that comprised the scale did not span the full range of person abilities 
of people with glaucoma. Additionally, in people with glaucoma the Impact of Vision Impairment 
questionnaire did not correlate statistically significantly with visual impairment (e.g., visual field). 
Across several studies, the construct measured by the Impact of Vision Impairment questionnaire 
was described as both a measure of QoL and a measure of participation, the terms used 
interchangeably (Lamoureux, Hassess, & Keeffe, 2004; Noe, Ferraro, Lamoureux, Rait, & Keeffe, 
2003).  
The most frequently used measure of VSQoL is the National Eye Institute Visual Function 
Questionniare-25 (VFQ-25; Dougherty & Bullimore, 2010; Mangione et al., 2001; Marella et al., 
2010; Massof, 2002; Revicki, Rentz, Harnam, Thomas, & Lanzetta, 2010; Suner et al., 2009). It is 
a reliable and validated instrument (Dougherty & Bullimore, 2010; Mangione et al., 2001). We 
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included the VFQ-25 in this research project as the measure of VSQoL. The psychometric 
properties of the VFQ-25 have been evaluated in people with various eye conditions, including 
age-related macular degeneration, age-related cataracts, glaucoma, diabetic retinopathy, and 
cytomegalovirus retinitis. A consistent trend in the relationship between VFQ-25 scores and visual 
field loss was reported in the literature: lower VFQ-25 scores for people with visual field loss than 
for people without visual field loss. This relationship between VFQ-25 scores and visual field loss 
indicated greater visual disability and poorer QoL (Gutierrez et al., 1997; Jampel et al., 2002; 
Kulkarni, Mayer, Lorenzana, Myers, & Spaeth, 2012; McKean-Cowdin et al., 2008; Richman et 
al., 2010). A large effect on VSQoL was demonstrated in people with both central and peripheral 
visual field loss, a moderate effect was demonstrated in people with binocular peripheral visual 
field loss, and a small effect was demonstrated in people with a monocular peripheral visual field 
loss (McKean-Cowdin et al., 2008). 
The popular use of the VFQ-25 in studies of people with glaucoma is likely related to its 
statistically significant correlation with visual field staging systems and its fair correlation with 
visual impairment outcomes (Altangerel, Spaeth, & Rhee, 2003; Jampel et al., 2002; Kulkarni et 
al., 2012). The status of the better-seeing eye demonstrated a closer relationship with VFQ-25 total 
scores than the status of the worse-seeing eye (van Gestel et al., 2010). The degree of binocular 
visual field loss and the status of the visual field of the better-seeing eye most accurately predicted 
functional ability and VSQoL (Kulkarni et al., 2012; Richman et al., 2010).  
While glaucoma-specific questionnaires may be more sensitive to the effects of disease and 
course of treatment, clinically more relevant, and narrower in scope, their psychometric rigor 
requires further validation. The current glaucoma-specific VSQoL instruments (e.g., Glaucoma 
Quality of Life-15) tend to measure only one aspect of the broad conceptualization of QoL (e.g., 
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symptoms related to interventions or satisfaction with interventions; Khadka et al., 2013). 
Additionally, they often have an insufficient number of items which results in inadequate 
measurement precision when evaluated for psychometric rigor using Rasch analysis. Rasch 
analysis is the theoretical method advocated by vision science researchers for instrument 
development and for testing the psychometric properties of ordinal-scaled instruments (Massof, 
2002). 
When using and interpreting VSQoL data, we need to take into account not only the effect 
of the progression of visual field loss as it relates to functional abilities but also recognize that 
different patterns of visual field loss have different effects on functional abilities. For example, 
VSQoL was more affected by the presence of binocular defects in the inferior visual field than by 
defects in the superior visual field (van Gestel et al., 2010). It is important to take into consideration 
that the consistency of people’s ratings and meaningfulness attached to those ratings may shift 
over time and alter by circumstance (Levasseur, Desrosiers, & St-Cyr Tribble, 2008). For example, 
having had glaucoma surgery resulted in lower VSQoL scores related to post-surgical symptoms. 
Likewise, the side effects of glaucoma medications negatively influence VSQoL. Notably, poorer 
VSQoL was also attributed to merely having a diagnosis associated with visual impairment, the 
inconvenience and burden of treatment regimens, and the cost of treatment (Iester & Zingirian, 
2002). Thus, VSQoL is multidimensional and measures several areas of life domains and is 
affected by environmental and psychosocial factors.  
2.1.2 Participation: Conceptual Definition 
Participation is a core concept in the ICF model to measure function and disability. Conceptually, 
participation is defined as individual’s involvement in life situations. There are nine domains that 
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comprise the taxonomy for participation in the ICF: 1) learning and applying knowledge, 2) 
general tasks and demands, 3) communication, 4) mobility, 5) self-care, 6) domestic life, 7) 
interpersonal interactions and relationships, 8) major life areas, and 9) community, social, and 
civic life. In vision rehabilitation, the effects of glaucoma on individuals’ daily living are measured 
by participation (i.e., abilities to accomplish life situations). Therefore, it becomes evident that 
participation is a direct outcome (i.e., mechanism of change) for the goals that are a part of the 
plan of care for intervention in vision rehabilitation. However, in research, there is no consensus 
on a criterion standard for defining and measuring participation (Levasseur, Richard, Gauvin, & 
Raymond, 2010). 
Despite the wide adoption of the ICF, there is a lack of conceptual clarity in regard to 
defining and distinguishing mutually exclusive taxonomies between the activity and participation 
constructs (Whiteneck & Dijkers, 2009). While activity and participation are two separate 
constructs in the ICF, they share the taxonomy that includes the aforementioned nine domains (see 
Table 5). The ICF offers four options to distinguish activity from participation and recommends 
that users should individually decide which option to choose. However, there is no consensus in 
the scientific literature as to which recommendation is the best distinction. Because of this 
conceptual ambiguity, researchers have recommended alternative conceptualizations of and 
differentiation between activity and participation (Badley, 2008; Nordenfelt, 2003; Whiteneck & 
Dijkers, 2009).  
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Table 5. The International Classification of Functioning, Disability and Health Taxonomy for 
Activities and Participation 
Domains 
1) Learning and applying knowledge 
2) General tasks and demands 
3) Communication 
4) Mobility 
5) Self-care 
6) Domestic life 
7) Interpersonal interactions and relationships 
8) Major life areas 
9) Community, social and civic life 
Recommendations 
1) Mutually exclusive sets of activities domains and participation domains 
2) Partial overlap between sets of activities and participation domains 
3) Detailed categories within domains classified as activities and broad categories within domains as 
participation, with or without overlap 
4) Use of the same domains for both activities and participation 
Note. From World Health Organization (2001). 
 
In regard to the conceptualization of activity differentiated from participation, a review of 
the literature suggested the distinction that activity is performance at the individual level of 
function and participation is performance at the societal level of function (WHO, 2001; Whiteneck 
& Dijkers, 2009). Simply stated, we can interpret this conceptual distinction as activity is done 
alone and participation is done in the company of or for others (i.e., social situations). Participation 
therefore, may better embrace the complexity and dynamic nature of human function better than 
activity as the solitary execution of a task (Desrosiers, Noreau, & Rochette, 2004; Levasseur et al., 
2008). As with QoL, the conceptual ambiguity for participation also results in operational 
disparities for instrument design and outcome measurement (Resnik & Plow, 2009). While 
minimizing activity limitations tends to be the typical intervention goal in traditional medical 
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rehabilitation settings, reducing participation restrictions may be the ultimate goal of vision 
rehabilitation given the effects of glaucoma on daily living and the relationship between 
participation and social role performance of people with glaucoma. 
In this study, we distinguished participation from activity as described by Whiteneck and 
Dijkers (2009) by stating that participation requires a social context involving other people and is 
more complex than activities, in that participation broadly encompasses a combination of several 
activities. We used the method to distinguish the activities and participation taxonomy into distinct 
sets of activity domains and participation domains with no overlap (WHO, 2001). Participation in 
this study is defined by the following three distinct ICF domains: 1) interpersonal interactions and 
relationships, 2) major life areas, and 3) community, social, and civic life.  
2.1.2.1 Disability Creation Process  While the ICF is the theoretical framework for 
operationalizing QoL and participation for this research project, we used a participation 
instrument, the Assessment of Life Habits, which is based on the DCP model. Therefore, 
recognizing the similarities and differences in their theoretical conceptualization of participation 
is important for understanding the application and interpretation of the Assessment of Life Habits. 
The underlying conceptualization of participation is critical in the process of defining what 
constitutes a participation situation. 
In the DCP model, participation is defined by life habits, which are defined as regular 
activities and social roles that ensure people’s survival and well-being in society throughout their 
lifespan (Fougeyrollas & Noreau, 2003). The term in the DCP model ‘capabilities’ is equivalent 
to ‘activities’ in the ICF model, not to be confused with the DCP term ‘regular activities’ used to 
define life habits (see Figure 1A). There are 12 domains of life habits in the DCP model. When 
the DCP model was compared to the ICF model, there are six life habits (DCP) that are similar to 
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the conceptualization and operationalization of participation (ICF) previously described: 1) 
interpersonal relationships, 2) education, 3) employment, 4) community life, 5) recreation, and 6) 
responsibilities (see Table 6; Levasseur, Desrosiers, & Tribble, 2007). Therefore in this study, we 
analyzed only the six life habits (i.e., social roles) on the Assessment of Life Habits instrument 
that are equivalent to the conceptualization of participation in the ICF. 
 
Table 6. Participation versus Activities: Similarities between the International Classification 
of Functioning, Disability and Health and the Disability Creation Process Models 
ICF  DCP (Life habits) 
Activities  Regular activities 
Learning and applying knowledge   
General tasks and demands   
Communication  Communication 
Mobility  Mobility  
Self-care  Personal care 
  Fitness 
  Nutritiona 
Domestic life  Housing  
  Nutritiona 
   
Participation  Social Roles 
Interpersonal interactions and relationships  Interpersonal relationships 
Major life areas  Education 
  Employment  
Community, social, and civic life  Community life 
  Recreation 
  Responsibilities 
Note. ICF = International Classification of Functioning, Disability and Health; DCP = 
Disability Creation Process. Participation is delineated from activities as suggested by 
Whiteneck & Dijkers (2009).  
aNutrition in the DCP relates to both self-care and domestic life in the ICF. 
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2.1.2.2 Participation: Measurement  Participation can be measured in terms of frequency 
of participation, participation accomplishment, and satisfaction with participation. Because of the 
conceptual ambiguities surrounding the distinction between activities and participation, 
participation is an evolving outcome in rehabilitation and the best methods for measuring 
participation are yet unclear. 
Multiple questionnaire-based instruments have been developed to measure participation, 
though the psychometric rigor of the newer instruments is not well established. Yet, despite 
existing participation instruments and the ultimate goals of vision rehabilitation to maximize 
participation in meaningful occupations, few studies on participation have been conducted with 
people with glaucoma. The number of studies on participation of people with glaucoma is likely 
to increase due to recent efforts to develop and/or modify existing instruments that distinguish the 
construct of participation from other constructs (e.g., QoL and activities) in response to the 
growing focus on participation as a measure of function and disability. A limitation of existing 
participation instruments is that several are designed for specific populations (e.g., brain injury), 
which may limit the instruments’ measurement of people’s abilities across a range of tasks with 
different complexities for different diagnostic populations. Few instruments have been used with 
or developed for people with glaucoma. Several participation instruments potentially relevant to 
use with people with visual impairment or glaucoma are the Impact of Participation and 
Autonomy, Participation Assessment with Recombined Tools-Subjective, Participation 
Assessment with Recombined Tools-Objective (PART-O), and Assessment of Life Habits (LIFE-
H; see Table 7). 
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Table 7. Instruments used to Evaluate Participation in Rehabilitation 
Instrument Number of items Domains 
IPA 32 Autonomy indoors 
Family role 
Autonomy outdoors 
Social life and relationships 
Work and education 
   
PART-S 11 School and other opportunities to learn 
Paid and unpaid work 
Having/raising children 
Housekeeping and other activities to keep the home in good order 
Relationships: spouse or significant other 
Relationships: family and relatives 
Relationships: friends and acquaintances 
Public and private transportation 
Participation in religious services and functions 
Activities in organizations or community 
Recreation and leisure 
   
PART-O 24 Productivity 
Social relations 
Out-and-about in the community 
   
LIFE-H 77 Nutrition 
Fitness 
Personal care 
Communication 
Housing 
Mobility 
Responsibilities 
Interpersonal relationships 
Community life 
Education 
Employment 
Recreation 
Note. IPA = Impact on Participation and Autonomy; PART-S = Participation with Recombined Tools-
Subjective; PART-O = Participation Assessment with Recombined Tools-Objective; LIFE-H = 
Assessment of Life Habits. 
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The Impact on Participation and Autonomy is a reliable and validated 32-item instrument 
developed to measure people’s perceptions of their participation (i.e., how likely they will be able 
to participate) and autonomy (i.e., how disability effects their ability to participate; Magasi & Post, 
2010; Sibley et al., 2006). It has been used with people across a wide spectrum of rehabilitation 
diagnoses and healthy adults, though not with people with visual impairment. It was developed 
based on the ICIDH-2 model. We did not use the Impact on Participation and Autonomy because 
our research questions were about how frequently and how individuals accomplished life situations 
and the research questions did not focus on the concept of autonomy. 
The Participation Assessment with Recombined Tools-Subjective was developed to 
measure people’s perceptions of their satisfaction for how they participate in home and community 
tasks. It is a separate scale from the Participation Assessment with Recombined Tools-Objective 
(PART-O). Its psychometric properties have not yet been published (Whiteneck et al., 2011). It 
has 11 domains of participation for which respondents rate the importance of each domain and 
their level of satisfaction with their participation in each domain area. It was developed based on 
the ICF model. We did not use the Participation Assessment with Recombined Tools-Subjective 
since its psychometric properties have not been reported. 
The PART-O is a reliable and validated 24-item instrument developed to measure the 
frequency of participation (Whiteneck et al., 2011). We included the PART-O in this research 
study as the measure of frequency of participation. The psychometric properties of the PART-O 
were evaluated using Rasch analysis in people with brain injury, spinal cord injury, stroke, and 
people in the general population with and without a disability. The instrument is unidimensional 
(i.e., measures one underlying construct). Reliability and validity values are within acceptable 
ranges for the Rasch model. The PART-O was developed within the past 5 years and only cross-
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sectional studies describing the instrument, mainly for its validation, were located in the published 
literature. It was developed based on the ICF model. 
The Assessment of Life Habits (LIFE-H) is a reliable and validated 77-item instrument 
developed to measure both participation (i.e., accomplishment) and satisfaction with participation 
(Fougeyrollas et al., 1998; Noonan, Miller, & Noreau, 2009; Noreau et al., 2004). We included the 
LIFE-H in this research project as the measure of participation accomplishment and satisfaction 
with participation. It demonstrated low ceiling and minimal floor effects (Magasi & Post, 2010). 
The LIFE-H is divided into 12 domains of life habits: 6 regular activities and 6 social roles. The 
psychometric properties of the LIFE-H accomplishment scale have been evaluated in diverse 
populations of people with varying conditions, including visual impairment, multiple sclerosis, 
spinal cord injury, stroke, older adults with disability, amputation, coronary disease, rheumatic 
disorders, and healthy people. The LIFE-H was used in a study of older adults with and without 
visual impairment and the study reported statistically significant differences in participation in 
regular activities and social roles between the two groups (Desrosiers, Wanet-Defalque, et al., 
2009). In the same study, the instrument demonstrated good reliability and weak to strong validity. 
Depressive symptoms and perceived quality of distant vision were the strongest correlates that 
together explained greater than 65% of the variance in the participation scores of people with visual 
impairment. It was developed based on the DCP model.  
Reliability and validity of the LIFE-H satisfaction with participation scale was studied 
separate from the LIFE-H accomplishment scales since it has its own score. A study of people 
described as having functional limitations explored the relationship between levels of participation 
and satisfaction with participation; the satisfaction with participation scale had a statistically 
significant and fair, positive association with the regular activities domains and total score (Poulin 
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& Desrosiers, 2009). In the same study, the satisfaction scale did not have a statistically significant 
association and only had a weak association with the social roles domains. Overall, the satisfaction 
scale had a moderate correlation with the participation accomplishment domain scales. The test-
retest reliability of the satisfaction scale was good for the regular activities domains, social roles 
domains, and the composite score. The satisfaction scale also had a stronger correlation to the 
Quality of Life Index than to the participation accomplishment domain scales, suggestive that 
satisfaction with how people were able to participate in everyday roles and routines was associated 
more with QoL than with performance.  
2.2 SUMMARY 
Over the past 15 years, glaucoma research has advanced. Healthcare now includes patient-reported 
outcomes to measure whether or not provided services improved patients’ perceptions of their 
health and well-being. Patient-reported outcomes are increasingly used with the focus on client-
centered care. Globally, vision science and medical care management included patient-reported 
outcomes that measured QoL as a means to understand the lived experiences of people with 
glaucoma in regard to their overall health and well-being (Labiris, Giarmoukakis, Larin, Gkika, & 
Kozobolis, 2012). A consistent trend in the literature is that VSQoL decreased as the severity of 
glaucoma increased and there were differences in the VSQoL of people with glaucoma compared 
to people without glaucoma (Freeman, Munoz, West, Jampel, & Friedman, 2008; Gutierrez et al., 
1997; Jampel et al., 2002; McKean-Cowdin et al., 2008). Additionally, there were perceived 
differences in VSQoL for people with mild stage glaucoma than those with severe stage glaucoma. 
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Recently, with an increased awareness of the role of and effectiveness of vision 
rehabilitation (i.e., evaluation and interventions), there is an increased focus on understanding the 
effects of glaucoma as they relate to function and disability. Participation is one outcome used in 
vision rehabilitation to measure the effects of vision loss on function and disability. The 
conceptualizations of both QoL and participation, however, have been ambiguous in the scientific 
literature. We described the conceptualization of QoL and participation as defined by the ICF to 
interpret the outcomes of this research project. In addition, we briefly described the current 
evaluation instruments used in both the medical and the rehabilitation management for people with 
glaucoma to summarize the state of the science in regard to glaucoma research and how the science 
is interpreted and applied clinically.  
While VSQoL has been a primary outcome in vision science to measure the effect of 
glaucoma on people’s daily living, we suggest that participation (the primary outcome measure 
used in vision rehabilitation to directly evaluate the effect of vision loss due to glaucoma on 
individuals’ abilities to accomplish social life situations) should be included in vision research. 
Yet, participation has not been well studied in people with glaucoma. We also contend that VSQoL 
and participation are two distinct constructs that can be used to measure the effect of glaucoma on 
people’s daily living, and that each contributes uniquely to our understanding of function and 
disability. Additionally, given there are conceptual similarities and differences between QoL and 
participation, arguably participation is one component included within the broader 
conceptualization of QoL (see Appendix A). Therefore, we designed this research project to 
explore participation in individuals with glaucoma, including a comparison to VSQoL, to better 
understand the association between participation and severity of glaucoma.  
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3.0  EXPLORING PARTICIPATION IN INDIVIDUALS WITH GLAUCOMA 
3.1 INTRODUCTION 
In health care and in research, there is an emerging focus to understand how glaucoma affects 
people’s abilities in regard to the accomplishment of roles and routines in daily living. Historically, 
research focused on how glaucoma affected the structure and function of the eye and the effect of 
glaucoma on people’s vision-specific quality of life (VSQoL). In recent years, the healthcare 
model of care shifted to a client-centered model where the client is encouraged to be an active 
stakeholder and their individual experiences are considered as integral to part of the care process. 
Vision rehabilitation services emerged in the forefront as part of the care process to meet 
individuals’ eye care needs. 
A primary goal of vision rehabilitation is for people to maximize the use of their remaining 
vision to live as independently as possible to engage in their chosen roles and routines. One 
outcome in rehabilitation that can be used to measure individuals’ accomplishment of roles and 
routines is participation. Clinically, rehabilitation specialists evaluate and develop intervention 
programs targeted toward maximizing participation when individuals experience disability related 
to vision loss. Participation is used to measure people’s responses to and the success of 
intervention. Yet, little vision research has focused on participation as a distinct outcome measure 
of function and disability in people with glaucoma; rather, the research to date focused primarily 
on VSQoL (see Section 2.0). Participation is an evolving outcome measure in rehabilitation 
research. How to best measure participation is still in developmental stages and, as previously 
described in Section 2.1.2, there are ambiguities in regard to the conceptualization of participation.  
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Participation in meaningful roles and routines is an important aspect of health, health 
management, and quality of life (Ellexson, 2004; Sørensen, Axelsen, & Avlund, 2002; Stevens-
Ratchford, 2010). The concept of participation, as taking part in doing something, is threaded 
throughout the gerontology literature. Studies explored how people engaged in tasks and how their 
engagement influenced successful aging; developmental theories suggest that participation 
patterns change across the lifespan, most especially among older adults (Bath & Deeg, 2005; 
Christiansen, Baum, & Bass-Haugen, 2005; Maier & Klumb, 2005; Sørensen, Axelsen, & Avlund, 
2002). 
3.2 PARTICIPATION: NORMAL AGING  
It is well documented that participation decreases with normal aging (Levasseur, Desrosiers, & St-
Cyr Tribble, 2008; Perlmutter, Bhorade, Gordon, Hollingsworth, & Baum, 2010; Sørensen et al., 
2002) and is more restricted by disabilities in older age (van Campen & Iedema, 2007). 
Participation in instrumental activities of daily living, leisure, and social activities were facilitators 
for remaining involved with families, communities, and social networks; sustaining health; and 
aging successfully (Glass, Seeman, Herzog, Kahn, & Berkman, 1995; Marsiske, Klumb, & Baltes, 
1997; Stevens-Ratchford, 2005). The presence of a disease, activities limitation, or participation 
restriction may alter people’s abilities to maintain their roles and routines; and in adapting to such 
changes, people may either cease engagement in a situation or change their level of engagement. 
Either way, there are changes in participation over time. For older adults, these changes in 
participation may lead to an inability to age in place and result in placement in long-term care 
facilities (Schoessow, 2010).  
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Limiting factors beyond age that influenced health and participation were decreased 
cognition and depression; each factor was associated with changes in participation (Perlmutter et 
al., 2010). Depressive symptoms or emotional distress were among the strongest correlates of 
lower participation in studies of people with physical and functional disability (Cardol et al., 2002; 
Desrosiers et al., 2006). As the Baby Boomer generation ages, the total percentage of the 
population aged 65 years and older will increase. Understanding the normal conditions of aging 
and how those conditions are managed will help direct resource utilization to support people’s 
involvement in social roles and routines (i.e., participation). However, while it is common to 
associate decreased levels of participation with normal aging, vigilance is warranted to 
discriminate when in fact the sequela of a chronic disease, such as glaucoma, is the true limiting 
factor of participation (Maier & Klumb, 2005; Mendes de Leon, 2005). 
3.3 PARTICIPATION: VISION LOSS 
For people with vision loss, their perceptions of their abilities to accomplish and ‘do’ a task (i.e., 
be involved in a life situation) was more important than the amount of their remaining vision that 
was still usable (severity of vision loss; Nelson, Aspinall, & O’Brien, 1999; Noe, Ferraro, 
Lamoureux, Rait, & Keeffe, 2003). The following determinants of participation were reported for 
people with vision loss: age, physical fitness, helplessness, social network size, and the personal 
value attached to participation (Alma, Van der Mei, Groothoff, & Suurmeijer, 2012). A point of 
interest from that study was that visual acuity, a measure of impairment, was not a determinant of 
participation. Visual acuity is often a benchmark measure used to indicate the presence of a visual 
impairment. In adults with chronic conditions, mobility and balance were indicators of 
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participation and characteristics such as age, depression, and comorbidities were not indicators of 
participation (Anaby et al., 2009). These findings contribute to the discussion that changes in 
participation may not be influenced by severity of impairment alone.  
Vision loss often co-occurs with other sensory conditions and the combination of 
conditions was associated with greater limitations on people’s abilities than either condition alone 
(Crews, Jones, & Kim, 2006). Dual sensory loss (e.g., the combination of vision and hearing loss) 
was present in 8.6% of older adults (Crews & Campbell, 2004) with 23% of adults aged 81 years 
and older having had some degree of dual sensory impairment that likely affected participation 
(Bergman & Rosenhall, 2001). The elderly who reported vision problems had a higher number of 
comorbidities compared to people without vision problems (Desrosiers, Wanet-Defalque, et al., 
2009). Studies of people with vision loss have identified associations between visual impairment 
and frequency of participation and mobility restrictions and visual field loss (Desrosiers, Wanet-
Defalque, et al., 2009; Noe et al., 2003). Decreased distant vision was associated with changes in 
participation and was a factor that influenced health and participation (Perlmutter et al., 2010). 
Overall, people with vision loss had statistically significant lower participation scores than people 
without vision loss (Desrosiers, Wanet-Defalque, et al., 2009; Renaud et al., 2010).  
People with glaucoma demonstrate characteristic behavior that is the consequence of both 
changes in vision and of the increased effort to overcome challenges in order to maintain 
independence in daily living. We know that gradual deterioration in vision may result from 
changes occurring in the body functions and the body structures of the eye that are not recognized 
until there is a degree of severity of change that is detectable by medical technologies. These initial, 
undetectable changes affect visual sensory perception and likely have subtle effects on higher level 
cortical sensory processing that may affect our abilities (e.g., motion perception for mobility and 
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driving). As previously stated, participation may be influenced by more than severity of 
impairment. Therefore, we asked the question whether or not participation would be an indicator 
of severity of vision loss independent of clinical measures of visual impairment.  
It is possible that people can fully compensate for a decline in clinical visual function by 
using strategies such as low vision aids or by doing tasks differently before they are diagnosed 
with an eye condition. These people may exhibit indicators for being at risk for disability, a 
functional state in which they are still able to accomplish daily roles and routines but they are 
changing the frequency or modifying the way in which they complete the tasks (Fried, Herdman, 
Kuhn, Rubin, & Turano, 1991; Higgins, Janelle, & Manini, 2013; West et al., 2005). This implies 
that these people with vision loss may be at risk for disability, but they do not perceive difficulties 
due to their use of compensatory strategies. For people with vision loss, participation may be an 
indicator of their risk for disability, demonstrating limitations in participation but not the lack of 
independence. 
The effect of glaucoma on people’s daily living and functional independence has justifiably 
received increased attention in regard to public health awareness. The prevalence of glaucoma in 
adults aged 40 years and older is increasing (Friedman et al., 2004). Participation is recognized in 
rehabilitation as a primary measure of the effect of impairment or disability on people’s 
accomplishment of their roles and routines. Yet despite the fact that a primary clinical goal of 
vision rehabilitation is to promote health through participation, by evaluating the effects of 
glaucoma on people’s abilities, participation has not been sufficiently studied. Moreover, the 
conceptual ambiguity surrounding the definition of participation (e.g., participation distinguished 
from activities) has received little attention in the design and interpretation of study results reported 
in the literature.  
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Based on the conceptualization of participation (i.e., a social context involving other 
people) previously described for this study, participation relates to more complex behavior than 
the execution of a singular task (i.e., activities). Glaucoma is associated with disability and loss of 
personal independence. Many of the effects of glaucoma on function and disability described in 
the literature are at the level of participation. Therefore, it is at the level of participation that may 
be most critical to evaluate in people with glaucoma to recognize behaviors that may be associated 
with severity of vision loss. 
The objective of this study was to explore participation in individuals with glaucoma to 
better understand the relationship between severity of vision loss related to the disease process and 
the degree to which participation was associated with severity of glaucoma. We currently know 
that participation decreases with the natural progression of aging and that it may also decrease in 
the presence of a health condition or disease. For individuals with glaucoma, we don’t know what 
participation is relative to the progression of the disease. This study aimed to explore the 
association between participation (frequency of participation, participation accomplishment, 
satisfaction with participation) and severity of glaucoma. We hypothesized that participation 
would have at least a moderate association with severity of glaucoma. 
3.4 METHODS 
3.4.1 Design  
A cross sectional design was used to examine the relationship between participation and severity 
of glaucoma. 
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3.4.2 Participants  
We recruited participants from the University of Pittsburgh Medical Center (UPMC) Eye Center(s) 
in Pittsburgh, PA from November 2013 to August 2014. Two methods were used for recruitment: 
1) clinical appointments at the UPMC Eye Center(s) and 2) the UPMC Eye Center Registry (a 
research registry of individuals who consented to be contacted about vision-related research 
conducted by the University of Pittsburgh). We directed our recruitment procedures to the patients 
of the physicians who were glaucoma specialists, including the clinical staff (e.g., fellows) under 
the physicians’ supervision. Patients were eligible to enroll in the study if they met the following 
criteria: 1) community-dwelling adult or older adult, 2) age 50 years or older, 3) medically 
diagnosed with glaucoma (not restricted by a specific type of glaucoma), and 4) best-corrected 
visual acuity (BCVA) of 20/200 or better in at least one eye. Patients were excluded from eligibility 
if they: 1) had a diagnosis of optic neuropathy or pathology other than glaucoma that was visually 
significant, 2) had a medical condition with subsequent vision loss, 3) were non-English speaking, 
or 4) had a cognitive impairment (defined by either a medical diagnosis or a Telephone Interview 
for Cognitive Status-modified [TICS-m] score ≤ 27). 
3.4.2.1 Modified Eligibility Criteria  We conducted two planned interim analyses of data 
in the early stages of our study to examine how the estimates that informed the statistical analysis 
plan were supported by our data. The first analysis was based on the first 15 enrolled participants 
with complete data; the second analysis was based on 51 enrolled participants. Per 
recommendation following the first analysis, the dissertation committee agreed to two eligibility 
criteria modifications. We modified the original inclusion criterion BCVA of 20/200 or better in 
both eyes to 20/200 or better in at least one eye. The rationale for this change was to minimize 
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the exclusion of individuals with more advanced glaucoma, who otherwise qualified for the study, 
and to potentially improve the distribution of the sample in regard to the spectrum of disease 
severity. We also modified the exclusion criterion for cognitive impairment defined by a TICS-
m score ≤ 31 to cognitive impairment defined by either a medical diagnosis or a TICS-m score ≤ 
27. The criterion change was supported by published research that reported individuals who 
scored as mild cognitive impairment (TICS-m score range 28 to 31) were accurate self-reporters. 
The University of Pittsburgh Institutional Review Board approved these changes, at which point 
36 participants were enrolled. No changes in study criteria were made after the second interim 
analysis. 
3.4.3 Instruments  
We used two procedures to screen for eligibility: 1) an electronic medical record (EMR) review 
and 2) an interview to screen cognition using the TICS-m. The descriptive and outcome 
assessments included: 1) EMR review, 2) Humphrey Visual Field Analyzer, 3) a demographic 
questionnaire, 4) the Participation Assessment with Recombined Tools-Objective (PART-O), and 
5) the Assessment of Life Habits (LIFE-H), version 3.1. 
3.4.3.1 Screening Instruments 
Electronic medical record review checklist. We created an EMR review screening checklist 
to screen patients’ medical records for eligibility for this study. The checklist included a yes/no 
response format as to whether the following information was recorded in the medical record: date 
of birth, living situation, medically diagnosed glaucoma, Humphrey Visual Field Analyzer test and 
mean deviation (MD) scores, BCVA, comorbidities with subsequent vision loss, diagnosed optic 
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neuropathy or pathology other than glaucoma, diagnosed cognitive impairment, English-speaking, 
and the date of the last clinical vision appointment (within 9 months of potential enrollment to the 
study). During an initial review of the EMR, yes/no was checked as to whether or not the 
information found in the EMR met the eligibility criteria for potential enrollment and whether the 
information was within the 9 month time parameter for eligibility for this study. The checklist is 
completed during an EMR review prior to any encounter with a patient (see Appendix B).  
Telephone Interview for Cognitive Status-modified. The TICS-m is a 13-item instrument 
developed to screen adults and older adults for cognitive impairment (see Table 8; de Jager, Budge, 
& Clarke, 2003). The TICS-m is a reliable and validated instrument (de Jager et al., 2003). TICS-
m scores had a weak, inverse correlation with age, moderate correlation with the Mini-Mental 
State Examination, and moderate correlation with the Cambridge Cognitive Examination. The 
normal distribution of TICS-m scores suggested it was less constrained by ceiling effects than both 
the Mini-Mental State Examination and the Cambridge Cognitive Examination, which each had 
skewed distributions. The TICS-m demonstrated 94% sensitivity and 100% specificity for 
grouping individuals as either normal cognition or impaired cognition (Martin-Khan, Wootton, & 
Gray, 2010). The memory tasks consist of higher item difficulty than other screening instruments; 
thus, it is a more discriminative test across the range of cognitive performance than the Mini-
Mental State Examination and the Cambridge Cognitive Examination. 
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Table 8. Domains of the Telephone Interview for Cognitive 
Status-modified 
Domains Number of items 
Orientation 3 
Registration/free recall 1 
Attention/calculation 2 
Comprehension, semantic and recent memory 5 
Language/repetition 1 
Delayed recall 1 
 
 
The maximum total score for the TICS-m is 39; a higher score indicates better cognitive 
function. A score of 31 or less is the optimal cut point to separate individuals with normal cognition 
from those with mild cognitive impairment; a score of 27 or less is the optimal cut point to separate 
individuals with mild cognitive impairment from those with dementia (Knopman et al., 2010). 
Patients were excluded from this study if they scored at or below 27. We chose to use the TICS-m 
to screen for cognitive impairment because it can be completed in 5 to 10 minutes either face-to-
face or via the telephone. 
3.4.3.2 Descriptive and Outcome Instruments 
Electronic medical record review checklist. We again used the EMR review screening 
checklist during a second review of the EMR after patients signed their consent to enroll in the 
study. We recorded the following information on the checklist: date of birth, mean deviation (MD) 
scores from the Humphrey Visual Field Analyzer test, clinical interpretation of the Humphrey 
Visual Field Analyzer test, BCVA, diagnosed comorbidities not indicated on the demographic 
questionnaires, and the date of the last clinical vision appointment. 
50 
Humphrey Visual Field Analyzer. The primary outcome variable for this study was the 
severity of glaucoma, defined by the MD of the better-seeing eye, measured by the Humphrey 
Visual Field Analyzer using the standard threshold 24-2 visual field test. The MD is a measure of 
visual field sensitivity through threshold testing using an automated perimeter; the measure is the 
deviation from the expected threshold value for a person of the same age and ethnicity. Individuals 
who are able to see dimmer thresholds than others of the same age and ethnicity have positive 
scores, while those individuals who require brighter threshold stimuli have negative scores. The 
mean deviation of the better-seeing eye is just as useful as more complicated strategies for staging 
the severity of glaucoma (Kulkarni, Mayer, Lorenzana, Myers, & Spaeth., 2012). The Humphrey 
Visual Field Analyzer is a threshold perimetry test developed to detect intensity of brightness 
respondents can see within the central 24 degrees of their visual fields. The Humphrey Visual Field 
Analyzer is considered the gold standard automated perimeter for the diagnosis and measurement 
of severity of glaucoma (Foster, Buhrmann, Quigley, & Johnson, 2002). Individuals who are able 
to see dimmer thresholds than others of the same age and ethnicity have positive scores (no or little 
impairment), while those individuals who require brighter threshold stimuli have negative scores 
(more severe impairment; see Table 2). MD scores for reliable tests range from 2 dB to -30 dB. 
The MD scores were dated within 9 months of enrollment to the study. 
We chose MD of the better-seeing eye for the measure of severity of glaucoma based on 
published research that reported the status of the better-seeing eye most accurately predicted 
functional ability, disability, and quality of life in individuals with glaucoma (Arora et al., 2013; 
Kulkarni et al., 2012). 
Demographic Questionnaire. The demographic questionnaire, developed specifically for 
this study, is comprised of three sections: 1) 12-items designed to collect background information 
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and eye and medical histories, 2) the Glaucoma Symptom Scale (GSS), and 3) the Patient Health 
Questionnaire-9 (PHQ-9). It can be self-administered or interview-administered in less than 5 
minutes (see Appendix B).  
The GSS is a 10-item instrument developed to measure visual problems experienced by 
respondents in the past 4 weeks; each eye is assessed separately (see Table 9; Lee et al., 1998). 
The GSS demonstrated discriminant validity between individuals with and without glaucoma, fair 
to moderate correlations with the National Eye Institute Visual Function Quationnaire-25 ocular 
pain subscale, and good internal consistency (Lee et al., 1998). Responses are rated on a 5-point 
categorical scale ranging from 0 (yes, very bothersome) to 4 (no, absent). The score for each item 
is transformed to a 0 to 100-point scale and the total score is the average of all 10 items; the score 
is reported for each eye individually or as an average for both eyes. A high score indicates no 
ocular complaints.  
 
Table 9. Visual Problems Assessed by the 
Glaucoma Symptom Scale 
Burning, smarting, stinging 
Tearing 
Dryness 
Itching 
Soreness, tiredness 
Blurry/dim vision 
Feeling of something in your eye 
Hard to see in daylight 
Hard to see in dark places 
Halos around lights 
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The PHQ-9 is a 9-item instrument developed to screen respondents for depressive 
symptoms experienced in the past 2 weeks (Kroenke, Spitzer, Williams, & Lowe, 2010; 
Lamoureux et al., 2009; Zhang et al., 2013). The PHQ-9 is a reliable and validated instrument 
(Gilbody, Richards, Brealey, & Hewitt, 2007; Kroenke, Spitzer, & Williams, 2001; Wittkampf, 
Naeije, Schene, Huyser, & van Weert, 2007). For individuals with vision loss, the PHQ-9 had no 
statistically significant deviation from the Rasch model and it was unidimensional (Lamoureux et 
al., 2009). Responses are rated on a 4-point categorical scale ranging from 0 (not at all) to 3 (nearly 
every day). The maximum total score is 27; a high score indicates the presence of greater 
depressive symptomology (see Table 10). The PHQ-9 includes a global rating of functional 
impairment (i.e., whether the symptoms identified make everyday activities difficult) which is not 
factored into the total score. The minimum recommended cut point to refer an individual for further 
formal testing for depression is 10 (Kroenke et al., 2001). At a score of 10 or greater, the PHQ-9 
demonstrated 88% sensitivity and 88% specificity for identifying major depression; individuals 
with major depression were 7 times more likely to have a score of 10 or greater. 
 
Table 10. Interpretation of the Patient Health 
Questionnaire-9 Scores 
< 5 No depressive symptoms 
5 - 9 Mild depressive symptoms 
10 - 14 Moderate depressive symptoms 
15 - 19 Moderately severe depressive symptoms 
≥ 20 Severe depressive symptoms 
 
 
Advantages of the PHQ-9 over other measures to screen for depressive symptoms include: 
shorter administration time; it consists of the actual nine criteria from the Diagnostic and Statistical 
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Manual of Mental Disorders for which the diagnosis of depressive disorders is based; performance 
by respondents was similar regardless of the method of administration; it performed similarly 
across sex, age, race, and ethnicity; and it was sensitive to clinically meaningful change (Kroenke 
et al., 2010). 
Participation Assessment with Recombined Tools-Objective. The PART-O is a reliable and 
validated 24-item questionnaire developed to measure frequency of participation in regard to 
respondents’ function in the household, family, and community and wider society (Whiteneck et 
al., 2011). It is divided into three areas of functioning: productivity, social relations, and out-and-
about in the community. Refer to section 2.1.2.2 for a brief description of the instrument’s 
psychometric properties.  
Assessment of Life Habits. The LIFE-H, version 3.1, is a reliable and validated 77-item 
questionnaire developed to measure: 1) how a respondent accomplishes regular activities and 
social roles (participation accomplishment) and 2) satisfaction with how regular activities and 
social roles are accomplished (satisfaction with participation; Fougeyrollas et al., 1998; Noonan, 
Miller, & Noreau, 2009; Noreau et al., 2004; Noreau, Fougeyrollas, & Vincent, 2002). Regular 
activities and social roles are life habits that are valued by people and ensure their survival and 
well-being in society throughout their lifespan (Fougeyrollas & Noreau, 2003). We used only the 
domains of life habits for social roles for this study because their meaning parallels the 
conceptualization of participation used for this study (see Table 6). There are six domains of life 
habits for social roles: 1) responsibilities, 2) interpersonal relationships, 3) community life, 4) 
education, 5) employment, and 6) recreation (see Table 11). Refer to section 2.1.2.2 for a brief 
description of the instrument’s psychometric properties.  
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Table 11. Social Roles Domains of the Assessment of Life Habits 
Domain  Taxonomy 
Responsibility Financial responsibility 
Civil responsibility 
Family responsibility 
  
Interpersonal relationships Sexual relationships 
Affective relationships 
Social relationships 
  
Community life Community participation 
Spiritual life and religious practice 
  
Education Pre-school 
Academic education 
Occupational training 
Other training 
  
Employment Guidance 
Job search 
Paid occupation 
Unpaid occupation 
  
Recreation Sports and games 
Arts and culture 
Socio-recreational activities 
Note. From Fougeyrollas, Cloutier, Bergeron, Cote, & St-Michel (1999). 
 
The participation accomplishment scale measures the level of difficulty and type(s) of 
assistance that are required to accomplish task performance (i.e., accomplishment; see Table 12); 
responses are rated on categorical scales. Respondents rate the level of difficulty and type(s) of 
assistance on categorical scales and the responses are converted to a 0 to 10-point scale (using a 
weighted formula) for each domain of life habits. A score of 0 indicates social roles are not 
accomplished and a score of 10 indicates social roles are performed without difficulty or 
assistance. The composite score for the participation accomplishment scale is the average of the 
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normalized scores for each domain of life habits. High scores indicate accomplishment of tasks 
with little or no difficulty and/or with few or no types of assistance. 
 
Table 12. Score Categories for the Assessment of Life Habits 
Participation accomplishment (/10)  Satisfaction with participation(/5) 
Level of difficulty Type(s) of assistance  Level of satisfaction 
No difficulty No assistance  Very satisfied 
With difficulty Assistive device  Satisfied 
Accomplished by a proxy Adaptation  More or less satisfied 
Not accomplished Human assistance  Dissatisfied 
Not applicable   Very dissatisfied 
Note. Assistive device = non-human support to assist in the accomplishment of a life habit (e.g., 
visual aid); adaptation = any modification to an individual’s environment to facilitate 
accomplishment of a life habit (e.g., lighting modifications); human assistance = a person assisting 
in the accomplishment of a life habit (includes supervision). 
 
The satisfaction with participation scale measures how satisfied individuals are with how 
they are able to accomplish task performance. Respondents rate their satisfaction with participation 
on a 5-point categorical scale ranging from 1 (very dissatisfied) to 5 (very satisfied). The domain 
score for each life habit is the average of all the items rated for that domain. The composite score 
for the satisfaction with participation scale is the average of all the domain scores. High scores 
indicate a high level of satisfaction with participation.  
The LIFE-H can be self-administered or interview-administered in approximately 40 
minutes. We chose the LIFE-H as a measure of participation accomplishment and satisfaction with 
participation based on its psychometric properties, clear distinction of the concept of participation 
versus activity, item content, and prior use with individuals with visual impairment (see Appendix 
B). 
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3.4.4 Procedure 
The study was approved by the University of Pittsburgh Institutional Review Board. We used two 
resources from which to screen potential participants: 1) we reviewed the clinical appointments 
scheduled for the glaucoma specialists at the UPMC Eye Center(s) and 2) we used the UPMC Eye 
Center Registry (see Figure 3). For patients scheduled for clinical appointments with the glaucoma 
specialists at the UMPC Eye Center(s), the primary investigator screened the patients’ EMRs using 
the EMR review checklist to identify any scheduled patients who potentially qualified for the study 
based on the eligibility criteria. This EMR review was conducted prior to a patient’s encounter 
with the physician. For those patients identified as potentially eligible for the study, a verbal 
permission form to allow the primary investigator to speak with patients to discuss the study was 
attached to their registration paperwork. Physicians then, at the conclusion of the patient’s 
appointment, verbally introduced the study to those patients who were earmarked potentially 
eligible for the study. The physicians completed the verbal permission forms by indicating (yes/no) 
whether or not the patients were interested in speaking with the primary investigator about the 
study. 
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Figure 3. Study Flow Diagram. 
 
For patients enrolled in the UPMC Eye Center Registry, a list of their names was provided 
to the primary investigator. All patients younger than age 50 years were removed from the list and 
the remaining names were then randomized using a random number generator. Screening 
procedures for the EMR review were conducted for only those patients who were diagnosed with 
glaucoma. Per UPMC Eye Center Registry protocol, the patients who met the eligibility 
requirements were contacted about the study via telephone.  
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The TICS-m was administered by the primary investigator to all patients who met the 
eligibility criteria following the first EMR review screening and who verbally expressed to the 
physician and/or primary investigator an interest in the study. After patients met the TICS-m 
eligibility criterion, their consent was obtained prior to administration of descriptive and outcome 
assessments per Institution Review Board protocol. Consent and assessment procedures were 
conducted either on the same day the patient was deemed eligible for the study or an appointment 
was scheduled to complete the assessments at a future date. Data were collected at the UPMC Eye 
Center(s), in participants’ homes, or at the University of Pittsburgh School of Health and 
Rehabilitation Sciences. The primary investigator administered, in order, the demographic 
questionnaire, PART-O, and LIFE-H per protocol. Testing took an average of 45 to 60 minutes to 
complete. After participants completed all the outcome assessments, the primary investigator 
performed a second review of the participants’ EMRs to document the testing results of their most 
recent clinical visual evaluations. 
3.4.5 Data Processing 
The Snellen BCVA scores that were recorded from the EMR to the EMR review checklist were 
transformed to logarithm of the minimal angle of resolution (logMAR) scale. We then relabeled 
the logMAR scores from ‘right eye’ and ‘left eye’ to the ‘better-seeing eye’ and ‘worse-seeing 
eye.’ The better- and worse-seeing eye designation for any variable was defined as such according 
to the eye with better BCVA (better-seeing eye) and worse BCVA (worse-seeing eye). The MD 
scores were also relabeled from ‘right eye’ and ‘left eye’ to ‘better-seeing eye’ and ‘worse-seeing 
eye.’ As a result of the multicollinearity diagnostic analyses (Cohen, Cohen, West, & Aiken, 2013; 
Field, 2009), we excluded reporting associations related to the MD and BCVA of the worse-seeing 
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eye. We transformed the comorbidity variable from yes/no, as to whether each comorbidity was 
present, to the total number of comorbidities participants indicated on the demographic 
questionnaire. 
For this analysis, participation accomplishment and satisfaction with participation were 
both measured by the LIFE-H. Each variable (participation accomplishment and satisfaction with 
participation) is measured by a separate scale and validated as separate measures of participation. 
Specifically, we reported the results for the domains of life habits that comprise the social roles 
scale (responsibilities, community life, interpersonal relationships, employment, and recreation). 
The meaning of these life habits, defined by the Disability Creation Process, are similar to the 
International Classification of Functioning, Disability and Health conceptualization of 
participation described for this study (see Table 6). We do not present data in regard to the 
education domain since this domain refers to current involvement in high school and entry-level 
training education programs which were not applicable to the participants in this study.  
We tested for violations of the assumptions of our variables for our statistical analyses 
(Field, 2009; Osborne & Waters, 2002). Multicollinearity was evaluated by examining the 
correlation among variables measuring a similar attribute; selection of those variables most 
appropriate to the interpretation of our results based on our objective were selected and results 
were reported based on theory and previously reported recommendations in the literature (Kulkarni 
et al., 2012; Richman et al., 2010; van Gestel et al., 2010). As a result of a bivariate analysis 
between composite scores and subscale scores for each participation measure, we performed our 
primary statistical analyses using the composite scores due to the multicollinearity between the 
composite scores and subscale scores. The distribution of the residuals for our outcome variable, 
severity of glaucoma (MD of the better-seeing eye), was not normally distributed (see Appendix 
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C). To address this violation, we transformed our data (Cohen et al., 2013; Field, 2009; Kleinbaum, 
Kupper, Muller, & Nizam, 1997). We adjusted the scale for MD scores so all scores were positive, 
severe glaucoma was still indicated by a low score and early glaucoma was indicated by a high 
score. We then transformed the variable using the fourth power transformation; normality was 
analyzed with P-P and Q-Q plots of the residuals, kurtosis and skewness, and a histogram. We 
analyzed the linear relationships of the standardized residuals and homoscedasticity with 
scatterplots. Our errors in the regression were independent (Durbin-Watson = 1.8; Field, 2009). 
All other assumptions were met within recommended parameters (Field, 2009; Osborne & Waters, 
2002). 
3.4.6 Statistical Analysis 
Data were entered, maintained, and analyzed using SPSS software, version 22 (IBM Corp., 
Armonk, NY). All data were de-identified and personal information was stored separately to 
ensure confidentiality in compliance with the standards of the University of Pittsburgh Institutional 
Review Board. Descriptive statistics were computed for participant demographics with means (M) 
and standard deviations (SD) for continuous variables and frequencies and percentiles for 
categorical variables.  
The level of significance was set at α = .05 for all statistical tests. The strength of the 
correlation coefficients was interpreted where a Spearman rho coefficient value less than .25 
indicates little or no correlation, between .25 to .49 indicates a fair correlation, between .50 to .74 
indicates a moderate to good correlation, and a value of .80 or greater indicates a good to excellent 
correlation (Cohen et al., 2003; Portney & Watkins, 2009). The magnitude of the importance of 
the standardized beta (?̂?) was interpreted where a value less than .20 indicates no to little 
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importance, between .20 to .49 indicates a minimal importance, between .50 to .79 indicates a 
moderate importance, and greater than .79 indicates a large importance (Ferguson, 2009).  
The aim was to explore the association between participation and severity of glaucoma (see 
Figure 4). To address this aim, we first performed a bivariate correlation analysis with the 
Spearman rho correlation coefficient, based on nonparametric variables, to explore the 
relationships between each measure of participation (frequency of participation, participation 
accomplishment, satisfaction with participation) and severity of glaucoma. We included in the 
correlation analysis demographic and clinical characteristics (covariates) to identify the variables 
that had at least a fair correlation (rho ≥ .25) and/or were statistically significant (p ≤ .05) with 
each measure of participation. 
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Figure 4. Statistical analyses to explore the association between participation and severity of 
glaucoma. 
To estimate to what extent participation was an indicator of severity of glaucoma, 
controlling for covariates, we performed a multiple regression analysis. Variables that had at least 
a fair correlation (rho ≥ .25), were statistically significant (p ≤ .05), and/or are known to associate 
with severity of glaucoma based on previous research were identified in the correlation analysis 
and included in the regression model. We initially proposed to perform the multiple regression 
analysis with each measure of participation entered individually for each model. However, 
frequency of participation did not qualify for nor contribute to our regression models in explaining 
the variance in severity of glaucoma so only participation accomplishment and satisfaction with 
participation were included in the regression models.  
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To test our hypothesis, we explored multiple regression models where severity of glaucoma 
was the dependent variable. Model 1 explored the relationship among covariates as indicators of 
severity of glaucoma. Model 2 explored the association between participation accomplishment, 
controlling for covariates, as an indicator of severity of glaucoma. Model 3 explored both 
participation accomplishment and satisfaction with participation, controlling for covariates, as 
indicators of severity of glaucoma. Covariates and participation measures were entered in a 
hierarchical order and based on the logic of our research; confounding variables were removed 
(Cohen et al., 2003). 
3.4.6.1 Sample Size  A sample size analysis conducted a priori determined that we needed 
to enroll 52 participants to achieve adequate power (80%,  = .05) to detect at least a fair to 
moderate effect size (rho ≥ .40) explaining a fair amount of variance in severity of glaucoma (R2 
= .40, ?̂? ≥ .40). Because there are a limited number of studies of participation for people with 
visual impairment, fewer yet for people with glaucoma, we referenced both the ranges of the 
correlation and linear association between vision-specific quality of life and severity of glaucoma 
reported in the literature. The rationale for this was twofold: 1) there was a lack of scientific data 
in regard to participation of people with visual impairment or glaucoma from which to generalize 
with robust confidence our predicted outcomes, and 2) our initial estimates were based on similar 
trends extrapolated from the literature between participation and quality of life in other 
populations in regard to severity of disability. We used data from published research based on the 
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National Eye Institute Visual Function Questionnaire-25 and MD of the better-seeing eye as the 
point of reference to estimate the relationship between participation and severity of glaucoma.  
3.5 RESULTS 
The objective of this study was to explore participation of individuals with glaucoma to better 
understand the relationship between severity of vision loss related to the disease process and the 
degree to which participation was associated with severity of glaucoma. 
3.5.1 Descriptive Data 
3.5.1.1 Participant Characteristics  A total of 90 participants enrolled in this study; 1 
participant withdrew from the study due to personal reasons prior to completing the assessments. 
Sixty seven participants were recruited from the UPMC Eye Center(s) and 22 were recruited from 
the UPMC Eye Center Registry. Participants were on average 68 years of age (ranging between 
50 and 89 years), predominantly female (67%) and Caucasian (78%), and nearly half (43%) had 
a graduate-level education (see Table 13, see Appendix D).  
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Table 13. Participants’ Demographic and Descriptive Characteristics 
Characteristic  M SD Range  n 
Age, years 68.0 9.2 50-89 89 
Length of glaucoma diagnosis, months 109.0 113.7     2-492 87 
Total number of comorbidities  1.8 1.5 0-7 89 
 Frequency   
Gender     
Male 33%  29 
Female 67%  60 
Race     
Asian   3%  3 
Black or African American 19%  17 
Caucasian 78%  69 
Other 2%  2 
Ethnicity     
Hispanic or Latino   1%  1 
Not Hispanic or Latino 99%  88 
Marital status     
Married 64%  57 
Divorced 17%  15 
Widow/er 10%  9 
Single 9%  8 
Living situation     
Alone 26%  23 
With spouse/partner 64%  57 
Other 10%  9 
Caregiver assistance   3%  3 
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Table 13 (continued) 
Characteristic Frequency  n 
Highest level of education     
Elementary   1%  1 
Secondary   9%  8 
Post high school 47%  42 
Graduate school 43%  38 
Annual income    86 
<$20,000 19%  16 
$20,000-$39,000 22%  19 
≥$40,000 59%  51 
Received glaucoma treatment 96%  85 
Topical medication 86%  73 
Oral medication   1%  1 
Laser 54%  46 
Other 38%  32 
Note. Other = implant surgery, trabectome, electrical brain stimulation, trabeculectomy, 
laser procedure prior to glaucoma diagnosis, canaloplasty. 
 
The average length of time since participants were diagnosed with glaucoma was 9 years. 
Participants had approximately 2 other medical conditions in addition to glaucoma (ranging 
between 0 and 7), with hypertension (38%), arthritis (31%), and respiratory conditions (21%) 
being the most common. Sixteen percent of participants reported having a hearing disorder.  
The severity of glaucoma (mean deviation [MD] of the better-seeing eye) on average was 
early stage (M = -4.25 dB, SD = 6.67 dB) and the average Snellen best-corrected visual acuity 
(BCVA, better-seeing eye) was approximately equivalent to 20/27 (M = 0.124 logMAR, SD = 
0.136 logMAR; see Table 14). Participants experienced symptoms associated with their glaucoma 
(GSS) but the symptoms were generally not bothersome (M = 76.1, SD = 18.8); the most 
bothersome problems were dryness in the eye and hard to see in dark places (see Appendix E). 
Participants on average did not experience many depressive symptoms (M = 2.7, SD = 3.4). The 
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most frequently reported depressive symptoms were trouble falling or staying asleep or sleeping 
too much (39.4%) and feeling tired or having little energy (53.9%). 
 
Table 14. Participants’ Clinical Characteristics 
   95% CI  
Characteristic  M SD LL UL n 
Clinical characteristics      
MD better seeing eye, dBa -4.25  6.67 -5.66 -2.85 89 
MD worse seeing eye, dBa -8.24 7.62 -9.89 -6.60 85 
BCVA better seeing eye, logMARb 0.124 0.136 0.096 0.153 89 
BCVA worse seeing eye, logMARb 0.268 0.266 0.210 0.326 84 
Glaucoma symptoms (/100)a 76.12 18.77 72.17 80.08 89 
Depressive symptoms (/27)b 
 
2.67 3.43 1.95 3.40 89 
Participation measures composite scores      
Frequency of participation (/3.17)c 2.08 0.47 1.98 2.18 89 
Participation accomplishment (/10)c 9.29 0.76 9.13 9.45 89 
Satisfaction with participation (/5)c 4.50 0.60 4.37 4.62 89 
Note. MD = mean deviation; dB = decibel; BCVA = best-corrected visual acuity; logMAR = 
logarithm of the minimal angle of resolution. 
aHigh score = less severe impairment. bHigh score = more severe impairment. cHigh score = 
greater participation. 
3.5.2 Participation 
For our sample, participants’ scores on each of the three participation measures on average were 
high. The average score for frequency of participation (PART-O) was 66% of the maximum total 
score (M = 2.08, SD = 0.47; see Table 14). In regard to the subscales for frequency of participation, 
out-and-about in the community had the highest average score (M = 2.37, SD = 0.63; see Appendix 
F). Within this subscale, participants were most likely to travel beyond their block or neighborhood 
(96.6%) and get out of their homes and go someplace 7 days per week (58.4%). In a typical month, 
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participants were least likely to go to a movie (52.8%) or attend a sports event as a spectator 
(74.2%) and more likely to attend spiritual or religious services (66.3%). 
Participants on average had little to no difficulty accomplishing tasks and required little 
assistance (i.e., assistive device, environmental modification, human assistance) to participate in 
life situations (i.e., participation accomplishment [LIFE-H]; M = 9.29, SD = 0.76; see Table 14). 
Similarly, participants on average were satisfied with how they were able to accomplish life 
situations (i.e., satisfaction with participation [LIFE-H]; M = 4.50, SD = 0.60).  
3.5.2.1 Recreation and Employment  The domains of life habits that were the most 
difficult for participants to accomplish, required some type(s) of assistance to accomplish, and/or 
participants were least satisfied with were recreation and employment (see Table 15). In regard 
to the recreation domain, a majority of participants actively participated in: sporting or 
recreational activities (e.g., sports, games; 86.5%), tourist activities (84.3%), and artistic or 
cultural events (e.g., concerts; 80.9%; see Appendix F). Of these three areas of recreation, 
participants had less difficulty or required little if any assistance going to artistic or cultural events 
(M = 8.14, SD = 1.56), while they had more difficulty and required some assistance participating 
in sporting or recreational activities (M = 7.69, SD = 2.07). In regard to satisfaction with 
participation, participants were most satisfied with how they accomplished attending artistic or 
cultural events (M = 4.43, SD = 0.89) and least satisfied with sporting or recreational activities 
(M = 4.04, SD = 1.11). The areas of the recreation domain for which the fewest number of 
participants participated in were going to sporting events as a spectator (51.7%) and taking part 
in outdoor activities (e.g., camping; 48.3%). 
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Table 15. Participants’ Domain Scores for the Assessment of Life Habits 
 Participation accomplishment  Satisfaction with participation 
   95% CI   95% CI 
Domain M SD LL UL  M SD LL UL 
Responsibilities 9.47 0.58 9.34 9.59  4.59 0.59 4.47 4.71 
Interpersonal 
relationships 
9.72 0.50 9.61 9.82  4.63 0.55 4.52 4.75 
Community life 9.26 0.80 9.10 9.43  4.51 0.68 4.37 4.65 
Employment 8.86 1.43 8.56 9.17  4.43 0.77 4.26 4.59 
Recreation 8.68 1.88 8.29 9.07  4.20 0.96 4.00 4.40 
 
In regard to the employment domain, a majority of participants actively participated in: 
unpaid activities (e.g., volunteering; 61.8%), getting to a principal place of occupation (e.g., work, 
volunteer location; 68.5%), and entering and moving around in a principal place of occupation 
(67.4%). Of these three areas of employment, participants had less difficulty or required little if 
any assistance moving around in a principal place of occupation (M = 8.57, SD = 0.62), while they 
had more difficulty and required some assistance taking part in unpaid activities (M = 8.27, SD = 
1.35).  
The same pattern was observed for satisfaction with participation: participants were most 
satisfied with how they accomplished moving around in a principal place of occupation (M = 4.58, 
SD = 0.72) and least satisfied with how they accomplished unpaid activities (M = 4.42, SD = 0.90). 
The areas of the employment domain for which the fewest number of participants participated in 
were choosing a career or profession (16.9%) and seeking employment (12.4%). Most participants 
were either well established in their careers or retired. However, for those participants who were 
seeking employment, approximately 36.4% experienced difficulty participating in this role and 
45.5% required some assistance. 
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3.5.2.2 Interpersonal Relationships and Responsibilities  The domains of the life habits 
that were the least difficult for participants to accomplish, required few if any assistance, and 
participants were the most satisfied with were interpersonal relationships and responsibilities (see 
Table 15). In regard to interpersonal relationships, a majority of participants actively participated 
in: maintaining friendships (100%), maintaining social relationships (98%), and maintaining 
close relationships with other members of their family (94%; see Appendix F). Participants had 
less difficulty or required little if any assistance maintaining friendships (M = 8.83, SD = 0.41), 
while they had more difficulty and required some assistance maintaining close relationships with 
other members of their family (M = 8.63, SD = 1.11). The same pattern was observed for 
satisfaction with participation: participants were most satisfied with how they accomplished 
maintaining friendships (M = 4.66, SD = 0.62) and least satisfied with how they accomplished 
maintaining close relationships with other members of their family (M = 4.56, SD = 0.78). 
In regard to responsibilities, a majority of participants actively participated in every area 
except ensuring the education of children and taking care of children. The area that participants 
had less difficulty or required no or little assistance was assuming personal or familial 
responsibilities (M = 8.72, SD = 0.56), while they had more difficulty and required assistance with 
making purchases (M = 8.34, SD = 1.07). In regard to satisfaction with participation, participants 
were most satisfied with how they accomplished their responsibilities towards others and society 
(e.g., voting; M = 4.72, SD = 0.56) and least satisfied with managing their budgets/meeting 
financial obligations (M = 4.47, SD = 0.79). 
71 
3.5.3 Aim 1: Explore the Association between Participation and Severity of Glaucoma 
3.5.3.1 Bivariate Correlation Analysis  The following covariates had at least a fair 
correlation and/or were statistically significant with frequency of participation, participation 
accomplishment, or satisfaction with participation: race, marital status, annual income, MD of the 
better-seeing eye, BCVA of the better-seeing eye, glaucoma symptoms, depressive symptoms, 
frequency of participation, participation accomplishment, and satisfaction with participation (see 
Table 16). Based on the covariates known to associate with participation from previous research, 
we included in the correlation analysis age, length of glaucoma diagnosis, and total number of 
comorbidities. Participation was not associated with age, length of glaucoma diagnosis, or the 
total number of comorbidities. Having a self-reported hearing disorder was statistically significant 
with participation accomplishment (rho = -.22, p = .04) but was not reported separately since it 
was included in the total number of comorbidities variable (see Appendix G). 
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Table 16. Correlation Analysis (Spearman rho) between Participation and Covariates 
 
Frequency of 
participation 
Participation 
accomplishment 
Satisfaction with 
participation 
  95% CI  95% CI  95% CI 
Characteristic 
Spearman 
rho LL UL 
Spearman 
rho LL UL 
Spearman 
rho LL UL 
Demographic          
Age, years .03 -.18 .24 .08 -.13 .28 .01 -.20 .22 
Length of 
glaucoma diagnosis 
-.01 -.22 .20 -.08 -.29 .13 -.15 -.35 .06 
Total number of 
comorbidities 
-.09 -.29 .12 -.04 -.25 .17 -.17 -.37 .04 
Race .35*** .15 .52 -.05 -.26 .16 -.08 -.28 .13 
Marital status -.33** -.50 -.13 -.06 -.26 .15 -.10 -.30 .11 
Annual income .48*** .30 .63 .25** .04 .44 .21 -.00 .40 
Clinical           
MD better-seeing 
eye, dB 
.17 -.04 .37 .28** .08 .46 .25* .05 .44 
BCVA better-seeing 
eye, logMAR 
-.16 -.36 .05 -.28** -.46 -.08 -.28** -.46 -.08 
Glaucoma 
symptoms 
.03 -.18 .24 .22* .01 .41 .38*** .19 .55 
Depressive 
symptoms 
-.21* -.40 -.00 -.26* -.44 -.06 -.46** -.61 -.28 
Frequency of 
participation 
   .22* .01 .41 .16 -.05 .36 
Participation 
accomplishment 
      .60*** .45 .72 
Note. MD = mean deviation, dB = decibel; BCVA = best-corrected visual acuity; logMAR = logarithm 
of the minimal angle of resolution.  
*p ≤ .05. **p ≤ .01. ***p ≤ .001. 
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Demographic Characteristics. Race and marital status had statistically significant, fair 
correlations with frequency of participation (rho = .35 and -.33, p < .01, respectively). There was 
little correlation between race and marital status with participation accomplishment and 
satisfaction with participation (rho ≤ -.05, p ≥ .34). Annual income had a statistically significant, 
fair correlation with both frequency of participation and satisfaction with participation (rho = .48 
and .25, p ≤ .05, respectively), but had little correlation (rho = .21, p = .06) with participation 
accomplishment. The majority of participants who reported an annual income of at least $40,000 
were Caucasian (90%). Notably, 64% of participants were married. Additionally, 76% of 
participants with either a post high school or graduate education were Caucasian. The relationship 
between frequency of participation and annual income was distinctly higher than that between 
satisfaction with participation and annual income.  
Clinical Characteristics. Impairment-based clinical measures of visual function (MD of 
the better-seeing eye, BCVA of the better-seeing eye, glaucoma symptoms) did not strongly 
correlate with frequency of participation (absolute rho ≤ .17, p ≥ .11) but rather had fair (absolute 
rho = .25 to .38) and/or statistically significant (p ≤ .05) correlations with participation 
accomplishment and satisfaction with participation. In regard to glaucoma symptoms of the better-
seeing eye, as previously stated the most bothersome problems were dryness in the eye and 
difficulty seeing in dark places. Dryness in the eye had little correlation (absolute rho ≤ .15, p ≥ 
.15) with any participation measure. Difficulty seeing in dark places had a fair and stronger 
correlation with satisfaction with participation (rho = .40, p < .01) than with participation 
accomplishment (rho = .23, p = .03). In general, the GSS composite score for the better-seeing eye 
had a fair correlation with satisfaction with participation (rho = .33, p < .01) but little correlation 
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with frequency of participation (rho = -.02, p = .85) or participation accomplishment (rho = .17, p 
= .12). 
Participants on average had no depressive symptoms, yet depressive symptoms had a fair 
and/or statistically significant relationship with each measure of participation. Further analysis 
indicated that participants who had depressive symptoms (PHQ-9 score < 5) participated less 
frequently in participation situations, accomplished participation with more difficulty and/or 
required some assistance, and were less satisfied with their participation compared to participants 
without depressive symptoms. The correlation between depressive symptoms and satisfaction with 
participation (rho = -.46, p < .01) was distinctly greater than the correlations with frequency of 
participation (rho = -.21, p = .04) and participation accomplishment (rho = -.26, p = .01). 
3.5.3.2 Multiple Regression Analysis  We performed a multiple regression analysis to test 
our hypothesis (see Table 17). The following variables were associated with severity of glaucoma, 
determined based on a correlation analysis, and included in the regression analysis: BCVA of the 
better-seeing eye, glaucoma symptoms, gender, participation accomplishment, and satisfaction 
with participation (see Appendix G). The following covariates, previously identified in the 
literature to associate with severity of glaucoma, did not substantially contribute to our regression 
models from which we determined the parsimonious models: age, length of glaucoma diagnosis, 
and total number of comorbidities (see Appendix H). Frequency of participation also did not 
contribute to our models for our analysis. The negative ?̂? for BCVA indicated that individuals 
with better BCVA had less severe glaucoma.  
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Table 17. Multiple Regression Analysis Models for Indicators of Severity of Glaucoma (Covariate and 
Participation Independent Variables) 
 Model 1 Model 2 Model 3 
Variables ?̂? R2 
Adjusted 
R2 ?̂? R2 
Adjusted 
R2 ∆R2 ?̂? R2 
Adjusted 
R2 ∆R2 
BCVA, 
logMAR 
-.31** .27 .25 -.21* .34 .31 .06* -.21* .36 .32 .02 
Glaucoma 
symptoms 
.27**    .23*    .28**    
Gender .23*    .20*    .23*    
Participation 
accomplish-
ment 
   .28**    .37**    
Satisfaction 
with 
participation 
       -.20    
Note. BCVA = best-corrected visual acuity of the better-seeing eye; logMAR = logarithm of the minimal angle of 
resolution.  
*p ≤ .05. **p ≤ .01. *** p ≤ .001. 
 
Regression Model 3 indicated the greatest proportion of the total variance in severity of 
glaucoma was explained by the independent variables included in the model (R2 = .36; see Table 
17). However, based on the adjusted R2, which represents a chance-adjusted value for R2 for the 
number of predictors included in a model (Portney & Watkins, 2009), Model 2 was the most 
parsimonious model which indicated that 31% of the variance in severity of glaucoma was 
explained by BCVA of the better-seeing eye, glaucoma symptoms, gender, and participation 
accomplishment. Participation accomplishment was a statistically significant, independent 
indicator of severity of glaucoma and had the largest magnitude of importance (?̂? = .28, p < .01) 
among all the variables in Model 2. However, the addition of satisfaction with participation in 
Model 3 did not produce a statistically significant R2 change (∆R2 = .02). Satisfaction with 
participation was not a statistically significant indicator (p = .09) and was associated with the 
lowest magnitude of importance in Model 3 (𝛽 ̂= -.20, p = .09). All measures of impairment and 
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gender (covariates) were statistically significant and independent indicators of severity of 
glaucoma (Model 2) when participation was included in the model. We were unable to support our 
hypothesis that participation would have at least a moderate association with severity of glaucoma. 
3.6 DISCUSSION 
This research study aimed to explore the association between frequency of participation, 
participation accomplishment, and satisfaction with participation with severity of glaucoma. The 
demographic of our sample did not reflect the demographic for people who are most at risk for 
glaucoma (e.g., African Americans aged 40 years and older). However, the sample did reflect the 
demographic of the greater Pittsburgh area and Allegheny County, Pennsylvania, in regard to 
gender, race, ethnicity, and level of education.  
Our findings were logical in that individuals who on average had early stage glaucoma and 
less severe impairment had high participation accomplishment and satisfaction with participation. 
Our findings suggested that while our participants were highly independent, a degree of that 
independence was achieved by using some type(s) of assistance (i.e., assistive device, environment 
or task adaptation, and/or human assistance). We found that frequency of participation had little 
correlation with severity of glaucoma and the relationship was not statistically significant. There 
was a stronger relationship between participation accomplishment and severity of glaucoma. This 
may be due to the fact that how often a person participates in selected life situations varies based 
on several factors other than glaucoma severity. In contrast, how someone accomplishes 
participation in life situations (i.e., through the use of compensatory methods) may be related to 
glaucoma severity. Our findings support the importance of recognizing that people who on average 
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had early stage glaucoma and less severe vision loss demonstrated participation among the 
incremental indicators of severity of glaucoma. Therefore, given these results, we suggest that 
participation may provide healthcare providers useful information and perspective about whether 
or not glaucoma is affecting patients’ accomplishment of everyday tasks even in the early stages 
of disease severity. This perspective may influence how general health care is evaluated and 
delivered in regard to the effect of disease on everyday living in addition to the effect of disease 
on the structure and function of the body.   
Our findings also support that subtle changes in people’s abilities to engage in daily living, 
roles, and routines may be affected by visual sensory perception which likely occurs in the early 
stage of glaucoma (Anderson, 2006; Bullimore et al., 1993; Canadian Ophthalmological Society 
Glaucoma Clinical Practice Guideline Expert Committee, 2009; Karwatsky, Bertone, Overbury, 
& Faubert, 2006; McKendrick, Badcock, & Morgan, 2005; Shabana, Pérès, Carkeet, & Chew, 
2003; Wolfe et al., 2012; Wu, Coffey, Reidy, & Wormald, 1998). We know that at the time of 
diagnosis, permanent vision loss has already occurred. Individuals who modify the way they 
complete tasks, but are still able to accomplish what they need to or want to do, may not perceive 
compensatory strategies as indicators of risk for a visual disability. The effects of glaucoma on 
function is often a hidden disability. We suggest that modifying the method to accomplish tasks 
may be an indicator of being at risk for disability (Fried et al., 1991; Higgins et al., 2013; West et 
al., 2005). Rodakowski (2014) demonstrated that preclinical disability measured by performance-
based tasks distinguished between older adults with normal cognitive function and older adults 
with mild cognitive impairment. Our findings suggest further study of the assessment of how 
people with glaucoma participate, as measured through self-report, and whether participation may 
discriminate between adults with and without vision loss. 
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In rehabilitation, clinicians evaluate how a health condition affects individuals’ abilities to 
accomplish their daily living. Participation is a level at which clinicians evaluate the interaction 
between individuals, the roles and routines they want to or need to do, and the contexts in which 
those roles and routines are performed. How that interaction influences individuals’ abilities for 
independence in regard to participation is the focal point for intervention. Yet little research has 
focused on describing participation in people with glaucoma. We found that participation was an 
independent incremental indicator of severity of glaucoma after controlling for covariates, which 
included clinical measures of visual impairment and gender. Specifically, participation 
accomplishment had a stronger association with severity of glaucoma than did satisfaction with 
participation. It is noteworthy that age and hearing loss (i.e., dual sensory loss) did not correlate 
strongly with severity of glaucoma in our sample.  
Participation may change over time; while some changes may result from normal aging, 
other changes may be due to health conditions, activity limitations, and/or participation 
restrictions. Our data suggest that even mild vision loss was associated with subtle adaptations in 
participation accomplishment. Without norms, it is difficult to comment on whether these 
adaptations are normal or indicators of decline. Certainly other studies report that vision loss has 
been associated with changes in participation (Desrosiers, Wanet-Defalque, et al., 2009; Hochberg 
et al., 2012; Noe et al., 2003; Perlmutter et al., 2010). That said, participation is an important 
component of the rehabilitation process when developing evaluation and intervention strategies. 
Additionally, we suggest an awareness that subtle changes in the methods people use to complete 
a task may be indicators of yet undetected or undiagnosed vision loss. This is important for 
specialists working in the broader healthcare process with people for whom vision loss may not be 
the primary reason for referral to their services.  
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Our study contributes to the current literature in that it is important to recognize and to 
further explore these factors in people with glaucoma to identify opportunities for prevention of 
the onset of disability. Currently, referral to vision rehabilitation for people with glaucoma 
typically occurs after there is significant, irreversible vision loss that already affects participation. 
Interestingly, frequency of participation had stronger correlations with socio-demographic 
variables (race, marital status, annual income) than the other indices of participation. Our sample 
on average participated more frequently than what was reported in published studies of patients 
with physical disabilities who participated in a hospital rehabilitation program and individuals 1 
year post traumatic brain injury with or without depression (Bogner et al., 2011; Hart et al., 2011). 
Although our sample did on average have lower frequency of participation compared to the general 
population with or without a disability (Bogner et al., 2011), our finding suggested that frequency 
of participation in individuals who on average had early stage glaucoma may relate more to socio-
demographic status and having the opportunity to engage in participation situations than to 
function and disability. 
Further exploring participation, we found that participants were more satisfied when they 
accomplished their life habits with little to no difficulty and with little if any type(s) of assistance. 
This is consistent with previous research that reported participants who performed better were 
more satisfied with their social participation (Levasseur, Desrosiers, & Noreau, 2004; Renaud et 
al., 2010). Desrosiers, Robichaud, et al. (2009) reported that older adults without a disability 
demonstrated decreased participation over time but no change in regard to their satisfaction with 
participation. Nelson, Aspinall, and O’Brien (1999) reported that loss of confidence in performing 
some routine daily tasks may actually precede self-reported vision-specific visual disabilities. 
These reports suggest that future study should incorporate measures of both participation 
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accomplishment and satisfaction with participation to understand the broader perspective of 
participation. Satisfaction with participation has been a determinant of overall participation in 
social roles (Alma et al., 2012).  
In this study, the life habits that were the most difficult for participants to accomplish and/or 
required some if any assistance were employment and recreation; the least difficult were 
responsibilities and interpersonal relationships. The same pattern was observed for satisfaction 
with participation. In previously reported studies of people with visual impairment, a similar trend 
was reported for recreation, responsibilities, and interpersonal relationships for participation 
accomplishment (employment was not included in the studies; Desrosiers, Robichaud, et al., 2009; 
Desrosiers, Wanet-Defalque, et al., 2009; Levasseur et al., 2004). Also, our results align with a 
previous study that reported employment challenges for people with vision loss and that only 
approximately 40% of working-aged adults with a visual impairment were employed (Bramley, 
Peeples, Walt, Juhasz, & Hansen, 2008). While the majority or our participants were not employed 
or were retired, of those who were seeking employment approximately 35% to 45% experienced 
difficulty and/or required some type(s) of assistance. 
Based on our participants who on average had early stage glaucoma, we suggest that 
responsibilities and interpersonal relationships are less dynamic and visually challenging, as they 
occur in more controlled and standard environments, than are employment and recreation, which 
occur in less controlled and shifting environments. We found that of the five participation life 
habits, only recreation and responsibilities were statistically correlated with severity of glaucoma. 
This finding highlights that people with glaucoma may verbalize or demonstrate different patterns 
of participation in social life situations at the time of their diagnosis or during early stages of the 
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disease that intuitively may not be expected to relate to vision loss based on clinical testing (Janz 
et al., 2001a).  
3.6.1 Conclusion  
We found that participation accomplishment was an independent incremental indicator of severity 
of glaucoma, after controlling for covariates and clinical measures of visual impairment. We also 
found that satisfaction with participation was reliably correlated with severity of glaucoma; 
individuals with more severe glaucoma had less satisfaction with their participation than those 
individuals with less severe glaucoma. Additionally, it may be less important to focus on frequency 
of participation of individuals with early stage glaucoma as a measure of severity of vision loss. 
These findings support that participation contributes to our understanding of function and 
disability of people with glaucoma. Our findings also provide evidence for further exploration as 
to how and whether or not individuals with glaucoma compensate for their vision loss by using 
strategies such as low vision aids or by changing the methods in which they complete tasks. While 
participation may change over time as a result of normal aging, we provided evidence of 
incremental indicators of severity of glaucoma associated with participation and that the patterns 
of participation may not be intuitive based on clinical testing and/or recognized during people’s 
engagement in daily living tasks.  
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4.0  PARTICIPATION AND VISION-SPECIFIC QUALITY OF LIFE RELATED TO 
SEVERITY OF GLAUCOMA 
4.1 INTRODUCTION 
The World Health Organization (WHO) stated that “health is a state of complete physical, mental, 
and social well-being and not merely the absence of disease or infirmity” (WHO, 2003). Since that 
conceptualization of health by the WHO, the effects of a disease and its influence on people’s daily 
living have increasingly been measured in research by the construct of quality of life (QoL). QoL 
is a multidimensional construct defined by the International Classification of Functioning, 
Disability and Health (ICF) as individuals’ subjective well-being in several areas of life domains 
(physical health, psychological health, level of independence, social relationships, the 
environment, and personal beliefs; WHO Quality of Life Group, 1993).  
In vision rehabilitation, the effects of a disease on individuals’ abilities to accomplish daily 
life situations are clinically measured by participation, not by QoL. Participation is considered a 
unidimensional construct of function and disability in the ICF, defined as an individual’s 
involvement in life situations. Historically, glaucoma research included vision-specific quality of 
life (VSQoL; i.e., the effect of ocular conditions and changes in function related to vision on health 
and well-being) as the primary construct used to both describe the experiences of people with 
glaucoma and to measure the effectiveness of vision rehabilitation (Labiris, Giarmoukakis, Larin, 
Gkika, & Kozobolis, 2012). Consequently, participation has not been directly measured as a 
primary construct, but rather described through the lens of QoL. Vision research only recently 
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began to include measures specific to participation in study designs to parse participation from 
within the multiple domains within VSQoL.  
4.1.1 Participation of People with Vision Loss and Glaucoma 
Refer to Sections 3.3 and 3.5 for a discussion of participation of people with vision loss and 
glaucoma. 
4.1.2 Vision-Specific Quality of Life of People with Glaucoma 
There is now a growing body of scientific literature to describe the unique experiences and the 
functional manifestations of vision loss of people with glaucoma as they relate to VSQoL. VSQoL 
was poorer as the severity of glaucoma worsened; VSQoL was statistically significantly different 
between the mild and severe stages of glaucoma while the moderate stage of glaucoma was 
generally not significantly distinct from either the mild or severe stages (Freeman, Munoz, West, 
Jampel, & Friedman, 2008; Goldberg et al., 2009; Gutierrez et al., 1997; Iester & Zingirian, 2002; 
Jampel et al., 2002; McKean-Cowdin et al., 2008; Nelson, Aspinall, & O’Brien, 1999; Nelson, 
Aspinall, Papasouliotis, Worton, & O’Brien, 2003). Factors associated with VSQoL of people with 
glaucoma included older age, a greater number of comorbidities, visual acuity of the better- and 
worse-seeing eyes, mean deviation (MD), difficulty using eye drops and adverse drug effects, 
perception of worsening health, and depressive symptoms (Freeman et al., 2008; Mangione et al., 
2001; Nassiri, Mehravaran, Nouri-Mahdavi, & Coleman, 2013).  
The progression of visual field loss that was associated with increasing severity of 
glaucoma has been shown to predict people’s functional abilities as measured by VSQoL (Iester 
& Zingirian, 2002; Qiu, Wang, Singh, & Lin, 2014; van Gestel et al., 2010). Additionally, research 
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reported that different patterns of visual field loss had more or less and different functional 
repercussions (Black, Wood, & Lovie-Kitchin, 2011; Lovie-Kitchin, Mainstone, Robinson, & 
Brown, 1990; Turano et al., 2004; van Gestel et al., 2010). The effects of glaucoma influenced 
VSQoL through both changes in vision (i.e., deterioration) and by the glaucoma treatment itself 
(Janz et al., 2001b; Nordmann, Auzanneau, Ricard, & Berdeaux, 2003). For example, having had 
a surgical procedure for medical management of glaucoma resulted in poorer VSQoL due to post 
surgical symptoms. People with glaucoma who respond similarly in regard to quantifying their 
VSQoL may differ in the severity of their glaucoma, their confidence in performing routine daily 
tasks, or how satisfied they feel about how they are able to accomplish their meaningful roles and 
routines.  
In this research study we specifically evaluated both participation and VSQoL. Because 
VSQoL has been well studied in people with glaucoma, we included a measure of VSQoL to 
compare our results to those published in the literature and as a point of reference to better 
understand and interpret the meaningfulness of our results in regard to participation. In the ICF 
model, QoL is not represented as a single construct of function and disability because it is 
multidimensional. Therefore, in regard to the relationship between severity of glaucoma and its 
effect on daily living, VSQoL is confounded by its multidimensional context that includes several 
areas of life domains. Participation is represented as a unidimensional construct of function and 
disability. Therefore, participation may be an indicator the severity of disease in regard to life 
situations affected by glaucoma, and less influenced by other confounding factors (see Appendix 
A). We contend that since participation is a primary measure used in vision rehabilitation to 
evaluate individuals’ abilities and to design intervention programs, participation should be studied 
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in glaucoma research to better understand disability and who is at risk for disability related to 
severity of vision loss. 
At the point at which people are diagnosed with glaucoma, structural and functional 
changes of the eye have already occurred. Because of what we know about visual sensory 
perception (see Section 1.1.1.1), people may have subtle differences in their abilities to accomplish 
daily living situations (i.e., participation) even in the early stage of glaucoma. People may still 
accomplish what they need to or want to do at some level of independence but they may establish 
different patterns of participation relative to decline in visual function by using strategies such as 
low vision aids or by doing tasks using a different method (Fried, Herdman, Kuhn, Rubin, & 
Turano., 1991; Higgins, Janelle, & Manini, 2013; West et al., 2005). Additionally, people may 
report that having some level of difficulty accomplishing a task affects their VSQoL. Therefore, 
we designed this study to compare participation and VSQoL.  
There is a need to better understand disability related to severity of vision loss. While the 
distinction between QoL and participation may not appear at first of consequence, their distinction 
is important. Arguably, VSQoL and participation are indeed two different constructs being blurred 
together to interpret research outcomes for clinical application. This trend may be related to the 
lack of instruments developed to measure well-defined constructs that parallel clinical practice, 
resulting in over-interpretation of data to compensate for measurement limitations. An increasing 
awareness of the blurred representation and whether or not it would be beneficial to distinguish 
between VSQoL and participation is needed to move vision science and practice forward to 
advance research and discriminately measure the constructs of VSQoL and participation. 
We designed this study to include data collection of VSQoL, an established evidence-based 
variable, to compare the relationship between participation and VSQoL as they each related to 
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severity of glaucoma. In most vision research designs, studies analyzed what factors were 
indicators or predictors of participation and VSQoL. In this research study, however, we were 
interested in whether or not participation and VSQoL were indicators of severity of glaucoma. We 
designed the study as such because research has suggested that the consequence of early stage 
vision loss on daily living may not align with (be predicted by) clinical measures of visual 
impairment (e.g., visual field), yet people who are diagnosed or at risk for disability may report 
subtle differences in their participation or QoL. For example, more severe visual field loss was a 
predictor of poorer VSQoL. Conversely, poorer VSQoL was associated with visual disability. 
Therefore, this study extends current research to specifically explore participation and VSQoL as 
indicators of severity of glaucoma.  
We measured participation in three ways: frequency of participation, participation 
accomplishment, and satisfaction with participation. Our intent was to explore participation since 
participation is the focal point for rehabilitation specialists to evaluate function and disability and 
develop intervention strategies. Knowledge of when and how disability occurs in people with 
glaucoma will inform medical care, improve patient safety in terms of treatment and prevention, 
and inform referral to vision rehabilitation. VSQoL was measured using a vision-specific 
instrument, the National Eye Institute Visual Function Questionairre-25 (VFQ-25). We 
hypothesized that participation would have a positive correlation (rho ≥ .40) with VSQoL, and that 
participation would have a stronger association with severity of glaucoma than VSQoL with 
severity of glaucoma. 
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4.2 METHODS 
4.2.1 Design 
A cross sectional design was used to examine the relationship between participation (frequency of 
participation, participation accomplishment, satisfaction with participation), VSQoL, and severity 
of glaucoma. 
4.2.2 Participants 
We recruited participants from the University of Pittsburgh Medical Center (UPMC) Eye Center(s) 
using two methods: 1) patients scheduled for clinical appointments with glaucoma specialists at 
the UPMC Eye Center(s) and 2) the UPMC Eye Center Registry. We sought the patients of 
physicians who were glaucoma specialists. Refer to Section 3.4.2 for a description of the 
recruitment methods and eligibility criteria. 
4.2.3 Instruments 
We used two procedures to screen for eligibility for this study: 1) an electronic medical record 
(EMR) review and 2) an interview to screen cognition using the Telephone Interview for Cognitive 
Status-modified (TICS-m). The descriptive and outcome assessments included: 1) EMR review, 
2) Humphrey Visual Field Analyzer, 3) a demographic questionnaire, 4) the Participation 
Assessment with Recombined Tools-Objective (PART-O), 5) the Assessment of Life Habits 
(LIFE-H), version 3.1, and 6) the VFQ-25. 
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4.2.3.1 Screening Instruments  Refer to section 3.4.3.1 for a description of the following 
screening instruments: electronic medical record review checklist and TICS-m. 
4.2.3.2 Descriptive and Outcome Instruments  Refer to section 3.4.3.2 for a description 
of the following outcome instruments: electronic medical record review checklist, Humphrey 
Visual Field Analyzer, demographic questionnaire, PART-O, and LIFE-H. In addition to these 
instruments, we included in this study the VFQ-25.  
National Eye Institute Visual Function Questionnaire-25. The VFQ-25 is a 25-item 
questionnaire developed to measure VSQoL. It was developed by RAND with funding from the 
National Eye Institute and is the most frequently used measure of VSQoL. The VFQ-25 is divided 
into 12 subscales (see Table 19). Refer to Section 2.1.1.1 for a description of the psychometric 
properties of the VFQ-25.  
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Table 18. Subscales of the Visual Function 
Questionnaire-25 
Subscales  Number of items 
General health 1 
General vision 1 
Ocular pain 2 
Near vision 3 
Distant vision 3 
Vision-specific social functioning 2 
Vision-specific role difficulties 2 
Vision-specific mental health 4 
Vision-specific dependency 3 
Driving 3 
Peripheral vision 1 
Color vision 1 
Note. General health is not included in the 25-item 
composite score. 
 
Responses for the VFQ-25 are either dichotomous (yes/no) or rated on scales that range 
from 3 to 6 categories. Each item score is transformed to a 0 to 100-point scale. The scores within 
each subscale are averaged for a subscale score and each subscale is subsequently averaged for a 
composite score; a high score indicates better visual function and VSQoL. The general health 
subscale is not included in the composite score. The VFQ-25 can be self-administered or interview-
administered in approximately 10 minutes (de Boer et al., 2004; see Appendix B).  
4.2.4 Procedure 
This study was approved by the University of Pittsburgh Institutional Review Board. We screened 
potential participants who were scheduled for clinical appointments at the University of Pittsburgh 
Medical Center (UPMC) Eye Center(s) with the glaucoma specialists and who were enrolled in 
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the UPMC Eye Center Registry. Refer to Section 3.4.4 for a description of the recruitment and 
enrollment processes.  
4.2.5 Data Processing 
We transformed the Snellen best-corrected visual acuity (BCVA) scores to logarithm of the 
minimal angle of resolution (logMAR) scale and the comorbidity variable from yes/no, as to 
whether each comorbidity was present, to the total number of comorbidities participants indicated 
on the demographic questionnaire. We relabeled the logMAR scores and mean deviation (MD) 
scores from ‘right eye’ and ‘left eye’ to the ‘better-seeing eye’ and ‘worse-seeing eye.’ Refer to 
section 3.4.5 for a detailed description of these data transformations.  
For this analysis, participation accomplishment and satisfaction with participation were 
both measured by separate scales on the LIFE-H, which was developed based on the Disability 
Creation Process. We reported the results for the domains of life habits that comprise the social 
roles domains (responsibilities, community life, interpersonal relationships, employment, and 
recreation) because the meaning of these life habits are equivalent to the ICF conceptualization of 
participation described for this study (see Section 2.1.2.1). We do not present data in regard to the 
education domain of life habits since this domain was largely not applicable to the participants in 
this study. 
 In regard to testing for violations of the assumptions of our variables for our statistical 
analyses, refer to section 3.4.5 for details in regard to multicollinearity diagnostic analyses and 
data transformation for our dependent variable (MD of the better-seeing eye) due to non-normally 
distributed residuals (Field, 2009; Osborne & Waters, 2002). Because of the multicollinearity 
between composite scores and subscale scores for each participation measure and the VFQ-25, we 
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performed our primary statistical analyses using the composite scores (Kulkarni, Mayer, 
Lorenzana, Myers, & Spaeth, 2012; Richman et al., 2010; van Gestel et al., 2010). We excluded 
reporting correlations based on the MD and BCVA of the worse-seeing eye. Our errors in the 
regression were independent (Durbin-Watson = 1.8; Field, 2009). All other assumptions were met 
within recommended parameters (Field, 2009; Osborne & Waters, 2002). 
4.2.6 Statistical Analysis 
Refer to section 3.4.6 for a description of our data entry and data processing procedures. 
Descriptive statistics were computed for participant demographics with means (M) and standard 
deviations (SD) for continuous variables and frequencies and percentiles for categorical variables.  
4.2.6.1 Aim 2: Explore the Relationship between Participation and Vision-Specific 
Quality of Life  The first aim of this study was to explore the relationship between participation 
(frequency, accomplishment, satisfaction) and VSQoL. We hypothesized that participation would 
have a positive correlation (rho ≥ .40) with VSQoL. To address this aim, a bivariate correlation 
analysis was performed with the Spearman rho correlation coefficient, based on nonparametric 
variables, to explore the relationship between each measure of participation and VSQoL (see 
Figure 5).  
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Figure 5. Statistical analyses to explore the relationship between participation (frequency, 
accomplishment, satisfaction) and vision-specific quality of life (VSQoL). 
4.2.6.2 Aim 3: Compare the Relationship between Participation and Vision-Specific 
Quality of Life as They Each Related to Severity of Glaucoma  The second aim for this study 
was to compare the relationship between participation and VSQoL as they each related to severity 
of glaucoma. We hypothesized that participation would have a stronger association to severity of 
glaucoma than VSQoL to severity of glaucoma. A bivariate correlation analysis was performed 
with the Spearman rho correlation coefficient, based on nonparametric variables, to explore the 
relationships among demographic and clinical characteristics (covariates), participation, VSQoL, 
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and severity of glaucoma to identify the variables that had at least a fair correlation (rho ≥ .25) 
and/or were statistically significant (p ≤ .05) with severity of glaucoma.  
To estimate to what extent participation and VSQoL were indicators of severity of 
glaucoma, controlling for covariates, we performed a multiple regression analysis (see Figure 5). 
Specifically, we were interested in the comparison of the relationship between participation and 
VSQoL as they each related to severity of glaucoma. Variables that had at least a fair correlation, 
were statistically significant, and/or are known to associate with severity of glaucoma (based on 
previous research) were identified and were included in the regression models.  
To test the hypothesis that participation would be a better indicator of severity of glaucoma 
than VSQoL, we explored regression models where severity of glaucoma was the outcome 
variable. Model 1 explored the relationship among covariates as indicators of severity of glaucoma. 
Model 2 explored the association between VSQoL and severity of glaucoma, controlling for 
covariates, and Model 3 explored each measure of participation and VSQoL, controlling for 
covariates, to compare their association as indicators of severity of glaucoma. We used the same 
decision process described in Section 3.4.6 to determine which variables to include in our 
regression models. 
4.2.6.3 Sample Size  A sample size analysis conducted a priori determined that we needed 
to enroll 37 participants to achieve adequate power (80%,  = .05) to detect a rho = .40 between 
participation and VSQoL. Using the same assumptions, we needed to enroll 67 participants to 
detect a rho = .30. Because there are a limited number of studies of participation of people with 
visual impairment and people with glaucoma, we used the ranges of the correlations between 
VSQoL and severity of glaucoma reported in the literature for our sample size analysis. The 
rationale for this was twofold: 1) there was a lack of scientific data in regard to participation (of 
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individuals with visual impairment or glaucoma) from which to generalize with confidence our 
predicted outcomes, and 2) we based our initial estimates on similar trends extrapolated from the 
literature between participation and QoL in other populations with chronic diseases in regard to 
severity of disability. We used data from published research based on the VFQ-25 and MD of the 
better-seeing eye as the referent to estimate the relationship between participation and VSQoL. 
Due to the limited scientific literature from which we predicted our outcomes, our power analysis 
was vulnerable. 
4.3 RESULTS 
The objective of this study was to explore participation in individuals with glaucoma to better 
understand the relationship between participation and severity of vision loss related to glaucoma 
and to explore the relationship between participation and VSQoL as they each related to severity 
of glaucoma.  
4.3.1 Descriptive Data 
4.3.1.1 Participant Characteristics  A total of 90 participants were enrolled in this study, 
1 participant withdrew from the study due to personal reasons prior to completing the 
assessments. Participants were recruited from both the UPMC Eye Center(s) and the UPMC Eye 
Center Registry. Participants were on average 68 years of age, predominantly female and 
Caucasian, and nearly half had a graduate-level education. The severity of glaucoma (mean 
deviation [MD] of the better-seeing eye) was early stage. Refer to Section 3.5.1 for more detail 
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in regard to the demographic characteristics (see Table 13) and the clinical characteristics (see 
Table 14) of the participants in this study. 
4.3.1.2 Participation  We used two instruments to measure three components of 
participation: the PART-O measured frequency of participation and the LIFE-H measured 
participation accomplishment and satisfaction with participation. Refer to section 3.5.2 for a 
detailed description and interpretation of participation data for the participants in this study. 
Frequency of participation was greatest for community engagement. Participants were most likely 
to travel beyond their block or neighborhood (96.6%) and least likely to attend a sports event as 
a spectator (74.2%).  
Participants on average had no difficulty accomplishing tasks and required little assistance 
to participate in life situations (M = 9.29, SD = 0.76; see Table 14), and were satisfied with how 
they were able to accomplish life situations (M = 4.50, SD = 0.60). Types of assistance to 
accomplish tasks are described by the LIFE-H as assistive devices, environmental or task 
modifications, and human assistance (see Table 12). Participants had the most difficulty 
accomplishing and were the least satisfied with how they accomplished recreation and 
employment domains of life habits, requiring some assistance. The domains of life habits that were 
the least difficult for participants to accomplish and participants were the most satisfied with how 
they were able to accomplish a life situation were interpersonal relationships and responsibilities, 
requiring little if any assistance.  
4.3.1.3 Vision-Specific Quality of Life  The average VFQ-25 composite score for our 
sample indicated that participants who on average had early stage glaucoma had very good 
VSQoL (M = 84.0, SD = 13.2; see Table 20). On average, participants rated their overall general 
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health (not included in the VFQ-25 composite score) good (M = 63.8, SD = 23.8) and general 
health was the lowest rated VFQ-25 subscale. In addition to general health, the following 
subscales had the lowest average scores (poorer VSQoL): general vision (scores indicated fair 
eyesight with correction when used [M = 75.1, SD = 15.2]), distant vision (scores indicated a little 
difficulty [M = 78.4, SD = 18.9]), and driving (scores indicated a little difficulty [M = 79.0, SD = 
17.7]). The subscales with the highest scores (better VSQoL) were color vision (M = 95.7, SD = 
11.5), vision-specific dependency (M = 93.7, SD = 13.5), and vision-specific social functioning 
(M = 93.0, SD = 13.3). All VSQoL indices were anchored by relatively small confidence intervals.  
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Table 19. Participants’ Scores for the Visual Function Questionnaire-25 
   95% CI  
 M SD LL UL n 
General health 63.8 23.8 58.7 68.8 89 
General vision 75.1 15.2 71.9 78.3 89 
Ocular pain  82.2 16.3 78.7 85.6 89 
Near vision  79.2 20.0 75.0 83.4 89 
Distant vision  78.4 18.9 74.5 82.4 89 
Vision-specific social functioning 93.0 13.3 90.2 95.8 89 
Vision-specific role difficulties 83.9 21.3 79.4 88.3 89 
Vision-specific mental health 80.9 20.8 76.5 85.2 89 
Vision-specific dependency 93.7 13.5 90.9 96.6 89 
Driving  79.0 17.7 75.0 83.0 77 
Peripheral vision  84.3 20.4 80.0 88.6 89 
Color vision  95.7 11.5 93.3 98.2 88 
Composite score  84.0 13.2 81.3 86.8 89 
Note. High score (/100) indicates better vision-specific quality of life. 
 
4.3.2 Aim 2: Explore the Relationship between Participation and Vision-Specific Quality 
of Life 
We performed a bivariate correlation analysis to test the hypothesis that participation would have 
a positive correlation (rho ≥ .40) with VSQoL. There was little correlation between frequency of 
participation and VSQoL (rho = .17, p = .11; see Table 21). Further exploring the relationship 
between frequency of participation and VSQoL subscales, productivity (i.e., home and work-
related roles) had a fair correlation with general health (rho = .25, p = .02). Additionally, out-and-
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about in the community had fair and/or statistically significant correlations with general vision, 
vision-specific dependency, and peripheral vision (rho = .27, .21, and .23, p ≤ .05, respectively).  
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Table 20. Correlation Analysis (Spearman rho) between Covariates, Participation, and Vision-Specific Quality 
of Life 
 
Frequency of 
participation 
Participation 
accomplishment 
Satisfaction with 
participation VSQoL 
  95% CI  95% CI  95% CI  95% CI 
Characteristic rho LL UL rho LL UL rho LL UL rho LL UL 
Demographic             
Age, years .03 -.18 .24 .08 -.13 .28 .01 -.20 .22 .09 -.12 .29 
Length of 
glaucoma 
diagnosis 
-.01 -.22 .20 -.08 -.29 .13 -.15 -.35 .06 .04 -.17 .25 
Total 
number of 
comor-
bidities 
-.09 -.29 .12 -.04 -.25 .17 -.17 -.37 .04 -.10 -.30 .11 
Race .35*** .15 .52 -.05 -.26 .16 -.08 -.28 .13 .03 -.18 .24 
Marital 
status 
-.33** -.50 -.13 -.06 -.26 .15 -.10 -.30 .11 -.06 -.26 .15 
Annual 
income 
.48*** .30 .63 .25** .04 .44 .21 -.00 .40 .25* .04 .44 
Clinical             
MD better-
seeing eye, 
dB 
.17 -.04 .37 .28** .08 .46 .25* .05 .44 .48*** .30 .63 
BCVA 
better-
seeing eye, 
logMAR 
-.16 -.36 .05 -.28** -.46 -.08 -.28** -.46 -.08 -.39*** -.55 -.20 
Glaucoma 
symptoms 
 .03 -.18 .24 .22* .01 .41 .38*** .19 .55 .60*** .45 .72 
Depressive 
symptoms 
-.21* -.40 -.00 -.26* -.44 -.06 -.46** -.61 -.28 -.35*** -.52 -.15 
Frequency of 
participation 
   .22* .01 .41 .16 -.05 .36 .17 -.04 .37 
Participation 
accomplish-
ment 
      .60*** .45 .72 .58*** .42 .70 
Satisfaction 
with 
participation 
         .62*** .47 .73 
Note. VSQoL = vision-specific quality of life, MD = mean deviation, dB = decibel; BCVA = best-corrected 
visual acuity; logMAR = logarithm of the minimal angle of resolution.  
*p ≤ .05. **p ≤ .01. ***p ≤ .001. 
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There were positive, moderate correlations between participation accomplishment and 
satisfaction with participation with VSQoL (rho = .58 and .62, p < .001, respectively). Exploring 
the relationships among the VFQ-25 and LIFE-H subscale scores indicated that VSQoL had 
statistically significant, fair to moderate correlations with nearly every LIFE-H subscale. The 
exceptions included (1) general health with the participation accomplishment subscales (rho ≤ .23) 
and (2) the VFQ-25 subscales with participation accomplishment of interpersonal relationships. 
Vision-specific social functioning (among the areas with the highest VFQ-25 scores) and general 
vision and near vision (among the areas with the lowest VFQ-25 scores) had the strongest 
correlations with participation accomplishment and/or satisfaction with participation.  
Participants’ responses indicated that recreation and employment were the two domains of 
life habits which were the most difficult to accomplish, required some assistance, and/or 
participants were the least satisfied with how they were able to accomplish them (see Table 15). 
In regard to participation accomplishment and satisfaction with participation, both recreation (rho 
= .58 and .65, p < .01, respectively) and employment (rho = .31 and .48, p < .01, respectively) had 
fair to moderate correlations with VSQoL. For recreation, the strongest correlations for 
participation accomplishment were with general vision and near vision (rho ≥ .56, p < .01), and 
for satisfaction with participation were general health and near vision (rho ≥ .61, p < .01). For 
employment, the strongest correlations for participation accomplishment were with general vision 
and peripheral vision (rho ≥ .33, p < .01) and for satisfaction with participation were with near 
vision and driving (rho ≥ .47, p < .01).  
4.3.2.1 Covariate Sub-Analysis  The following covariates had at least a fair correlation 
and/or were statistically significant with participation and/or VSQoL: race, marital status, annual 
income, MD of the better-seeing eye, BCVA of the better-seeing eye, glaucoma symptoms 
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(Glaucoma Symptom Scale [GSS]), depressive symptoms (Patient Health Questionnaire-9 [PHQ-
9]), frequency of participation (PART-O), participation accomplishment (LIFE-H), satisfaction 
with participation (LIFE-H), and VSQoL (VFQ-25; see Table 21). Neither participation nor 
VSQoL were associated with age, length of glaucoma diagnosis, or the total number of 
comorbidities.  
Race and marital status had little correlation with VSQoL (absolute rho ≤ .06, p ≥ .57). 
Annual income had a fair correlation with VSQoL (rho = .25, p = .02); notably, 64% of participants 
were married. The correlation between annual income and frequency of participation was distinctly 
stronger (rho = .48, p < .001) than the relationship between annual income and VSQoL.  
Impairment-based clinical measures of visual function (MD of the better-seeing eye, 
BCVA of the better-seeing eye) had a fair correlation with VSQoL (rho = .48 and -.39, p < .001, 
respectively) and indicated that participants with better visual function had better VSQoL. In 
regard to impairment-based clinical measures of symptoms (glaucoma and depressive symptoms), 
VSQoL had a moderate correlation with glaucoma symptoms (rho = .60, p <.001); which indicated 
that participants with fewer symptoms had better VSQoL. The most bothersome symptoms were 
dryness in the eye and hard to see in dark places (see Appendix E). Further exploring the 
relationships between these two symptoms, participation, and VSQoL, dryness in the eye had a 
fair correlation with only VSQoL (rho = .29, p < .01) while hard to see in dark places had fair to 
minimal correlations with participation accomplishment (rho = .27, p = .01), satisfaction with 
participation (rho = .43, p < .001), and VSQoL (rho = .52, p < .001). There was a pattern among 
MD of the better-seeing eye, BCVA of the better-seeing eye, and glaucoma symptoms in that these 
variables each had distinctly stronger correlations with VSQoL than with each of the three 
participation measures. Participants on average had no depressive symptoms, yet depressive 
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symptoms had a fair correlation with VSQoL (rho = -.35, p = .001). The correlation between 
depressive symptoms and VSQoL indicated that participants with fewer depressive symptoms had 
better VSQoL. 
Based on the 95% confidence intervals (see Table 20), our findings provide support for our 
hypothesis that participation would have a positive correlation (rho ≥ .40) with VSQoL for 
measures of participation accomplishment and satisfaction with participation but not for frequency 
of participation.  
4.3.3 Aim 3: Multiple Regression Analysis 
We performed a multiple regression analysis to test the hypothesis that participation would have a 
stronger association to severity of glaucoma than VSQoL with severity of glaucoma (see Table 
21). Based on our correlation analysis, the following variables had at least a fair correlation and/or 
were statistically significant with severity of glaucoma: BCVA of the better-seeing eye, glaucoma 
symptoms, gender, participation accomplishment, satisfaction with participation, and VSQoL (see 
Appendix G). The following covariates associated with participation and VSQoL previously 
identified in the literature did not substantially contribute to our regression analysis for which we 
determined the parsimonious regression models: age, length of glaucoma diagnosis, and total 
number of comorbidities (see Appendix H). Frequency of participation also did not contribute to 
our models for our analysis. The negative ?̂? indicated participants with better BCVA had less 
severe glaucoma, and participants who reported greater satisfaction had less severe glaucoma. 
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Table 21. Multiple Regression Analysis Models for Indicators of Severity of Glaucoma (Covariates, Vision-
Specific Quality of Life, and Participation Independent Variables) 
 Model 1 Model 2 Model 3 
Variables ?̂? R2 
Adjusted 
R2 ?̂? R2 
Adjusted 
R2 ∆R2 ?̂? R2 
Adjusted 
R2 ∆R2 
BCVA, 
logMAR 
-.31** .27 .25 -.20* .34 .31 .06** -.16 .40 .35 .06* 
Glaucoma 
symptoms 
.27**   .12    .17    
Gender .23*   .18*    .21*    
VSQoL    .33**    .33*    
Participation 
accomplish-
ment 
       .25*    
Satisfaction 
with 
participation 
       -.29*    
Note. BCVA = best-corrected visual acuity of the better-seeing eye; logMAR = logarithm of the minimal angle of 
resolution, VSQoL = vision-specific quality of life.  
*p ≤ .05. **p ≤ .01. *** p ≤ .001. 
 
The regression results indicated that 40% of the variance in severity of glaucoma was 
explained by the variables in Model 3 (see Table 21). Based on the adjusted R2, which represents 
a chance-adjusted value for R2 for the number of predictors included in a model (Portney & 
Watkins, 2009), Model 3 was also the most parsimonious model which indicated that 35% of the 
variance in severity of glaucoma was explained by BCVA of the better-seeing eye, glaucoma 
symptoms, gender, VSQoL, participation accomplishment, and satisfaction with participation. 
When participation accomplishment and satisfaction with participation were added to Model 3, the 
impairment-based clinical measures were no longer statistically significant indicators of severity 
of glaucoma. The R2 change between each model, while small, was statistically significant and 
indicated that the additions of VSQoL, participation accomplishment, and satisfaction with 
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participation were statistically significant contributors to understanding the variance in severity of 
glaucoma. Therefore, Model 3 was the most parsimonious model.  
VSQoL, participation accomplishment, and satisfaction with participation were each 
statistically significant (p ≤ .04) indicators and had the largest magnitude of importance (?̂? = .25 
to .33) among all the variables in the model; VSQoL had the largest magnitude of importance (?̂? 
= .33). However, the distinction in regard to the magnitude of importance between VSQoL, 
participation accomplishment, and satisfaction with participation was not large. Although based 
on the correlation analysis we identified at least a fair correlation between severity of glaucoma 
and the covariates BCVA of the better-seeing eye and glaucoma symptoms, these covariates were 
not statistically significant indicators of severity of glaucoma when regressed with participation 
measures and VSQoL. Comparing Models 2 and 3 in the regression analysis, the magnitude of the 
importance of VSQoL did not change relative to whether or not participation was included.  
Overall, this clearly indicates no great distinction between participation and VSQoL and 
the strength of their associations with severity of glaucoma were modest. Although these results 
indicated that participation did not have a stronger association to severity of glaucoma than VSQoL 
(our hypothesis), the strengths of the correlations were similar. 
4.4 DISCUSSION 
This research study aimed to: 1) explore the relationship between participation and VSQoL and 2) 
compare the relationship between participation (frequency of participation, participation 
accomplishment, satisfaction with participation) and VSQoL as they each related to severity of 
glaucoma. Our findings overall were logical in that for individuals who on average had early stage 
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glaucoma, they had high participation and VSQoL. We found that VSQoL and participation 
(accomplishment and satisfaction) had fair to moderate correlations with severity of glaucoma (see 
Appendix G). VSQoL, participation accomplishment, and satisfaction with participation were each 
independent incremental indicators of severity of glaucoma and similarly associated with severity 
of glaucoma. Previous studies reported that participation contributed to QoL (Ellexson, 2004; 
Levasseur, Desrosiers, & Noreau, 2004; Levasseur, Desrosiers, & St-Cyr Tribble, 2008; Sørensen, 
Axelsen, & Avlund, 2002; Stevens-Ratchford, 2005), satisfaction with participation contributed to 
social participation (Alma et al., 2012), and severity of vision loss was associated with QoL 
(Gutierrez et al., 1997; Iester & Zingirian, 2002; McKean-Cowdin et al., 2008; Parrish et al., 1997; 
van Gestel et al., 2010).  
4.4.1 Aim 2: Explore the Relationship between Participation and Vision-Specific Quality 
of Life 
We found positive, moderate correlations among VSQoL, participation accomplishment, and 
satisfaction with participation. These correlations suggested that for social life situations 
accomplished with little to no difficulty and with few if any type(s) of assistance, participants were 
satisfied with how they accomplished life situations and they reported greater perceptions of their 
well-being. These results are consistent with previous research that reported fair to moderate 
relationships between participation and VSQoL (Desrosiers, Wanet-Defalque, et al., 2009; 
Levasseur et al., 2004; Renaud et al., 2010). Similar to published studies, we found that individuals 
with worse severity of glaucoma reported lower VSQoL (Goldberg et al., 2009; Gutierrez et al., 
1997; Hyman, Komaroff, Heijl, Bengtsson, & Leske, 2005; Jampel et al., 2002; Labiris et al., 2012; 
McKean-Cowdin et al., 2008; Nelson et al., 2003; Richman et al., 2010; Ringsdorf, McGwin Jr, & 
Owsley, 2006; Suzukamo et al., 2005; van Gestel et al., 2010; Wren et al., 2009). In this study, our 
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finding that recreation (a life habit that was the most difficult for participants to accomplish, 
required some assistance to accomplish, and participants were the least satisfied with how they 
accomplished it) had the strongest correlation with VSQoL corroborated our previous suggestion 
that a more visually challenging task may be an important, early indicator of severity of vision 
loss. This finding in regard to a more visually challenging task also suggests that people’s 
decreased abilities to accomplish a life situation (i.e., recreation) may not be evident during visual 
testing but may become evident when evaluating participation.  
In our sample of individuals who on average had early stage glaucoma, our findings of the 
areas of better and worse VSQoL were consistent with previous research of people with glaucoma 
with the exception that our study participants reported worse VSQoL for distant vision while the 
majority of previous research reported instead vision-specific role difficulties (Hyman et al., 2005; 
Labiris et al., 2012; Lee et al., 1998; McKean-Cowdin et al., 2008; Nassiri et al., 2013; Parrish et 
al., 1997; Ringsdorf et al., 2006). Interestingly in this study, peripheral vision was not the most 
frequently reported vision-related difficulty, even though loss of peripheral vision is one of the 
hallmark characteristics ascribed to glaucoma to explain how glaucoma may first begin to affect 
function and behavior. This finding again emphasizes that people with glaucoma may verbalize or 
demonstrate visual-related behavior prior to their diagnosis or during the early stage of the disease 
that may not be detected through traditional clinical testing (Janz et al., 2001a). Mental versus 
physical indicators of QoL were scored lower on the VFQ-25 by people with glaucoma compared 
to people with other ocular conditions (Evans, Law, Walt, Buchholz, & Hansen, 2009). 
In general, the clinical measures of visual function (impairment) had stronger correlations 
with VSQoL than with participation. We suggest that knowledge about impairment affected 
participants’ perceptions of their state of health and well-being. Since physicians educate their 
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patients about changes in vision and severity of vision loss indicated by test results, patients’ 
perceptions’ about their state of health and well-being may be influenced by knowing glaucoma 
results in permanent loss of vision. Since testing rarely includes evaluation of patients’ 
accomplishment of daily living situations, people may tend to associate clinical symptoms of 
impairment more strongly with their state of health and well-being than with how they accomplish 
daily living situations. As impairment worsens, psychological burden increases together with a 
growing fear of blindness, social withdrawal, and depression (Janz et al., 2007; Ramulu, van 
Landingham, et al., 2012; Skalicky & Goldberg, 2008), all of which are recognized to affect 
VSQoL.  
Also in regard to impairment, glaucoma symptoms had a distinctly stronger correlation 
with VSQoL than with participation. Participants’ reports of difficulty seeing in dark places was 
consistent with previous literature which reported that people with glaucoma had difficulty 
adapting to sudden changes in light or darkness and had sensitivity to varying contrasts (Nelson et 
al., 1999; Nelson et al., 2003; Ramulu, 2009; Spaeth et al., 2006). Even though our sample overall 
had no depressive symptoms, depressive symptoms had, not surprisingly, stronger correlations to 
satisfaction with participation and VSQoL than with participation accomplishment.  
Frequency of participation had a weak correlation with VSQoL and stronger correlations 
to socio-demographic variables (race, marital status, annual income) than to clinical measures of 
visual impairment. This relationship was similar to what we reported in the previous chapter. 
Measures of visual impairment more strongly correlated with participation accomplishment, 
satisfaction with participation, and VSQoL than with frequency of participation. Therefore, 
frequency of participation may relate more to socio-demographic status and having the opportunity 
to engage in participation situations than to function and disability.  
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4.4.2 Aim 3: Compare the Relationship between Participation and Vision-Specific Quality 
of Life as They Each Related to Severity of Glaucoma 
Gender (female), VSQoL, participation accomplishment, and satisfaction with participation were 
indicators of severity of glaucoma. These findings are of particular interest since measures of 
clinical visual impairment such as visual acuity and glaucoma symptoms were not indicators of 
severity of vision loss for individuals who on average had early stage glaucoma. Our findings in 
regard to participation and measures of impairment were consistent with previous, yet limited 
research (Alma et al., 2012). We hypothesized that participation would have a stronger association 
with severity of glaucoma than did VSQoL, after controlling for covariates, but we did not find 
this result. However, our findings are important in that participation accomplishment, satisfaction 
with participation, and VSQoL were similar in regard to the strength of their association with 
severity of glaucoma. We suggest, therefore, that participation be further studied during routine 
medical care to elucidate whether or not participation is sensitive to identify vision-related deficits 
in patients’ accomplishment of daily living situations. Participation measures may be applied 
during a routine medical examination more so than a vision-specific measure. 
It is recognized that people with similar disease states such as glaucoma likely rate the 
effects of the disease on their QoL differently. When interpreting research that used self-report 
instruments to measure the effects of glaucoma on VSQoL, the consistency of self-report ratings 
and meaningfulness attached to ratings may shift over time and alter by circumstance (Levasseur 
et al., 2008), evidence of the multidimensional nature of VSQoL. Subjective measures can be 
influenced by people’s physical health, psychological health and coping strategies, social 
relationships, personal and cultural beliefs, personal expectations, socio-economic factors, value 
of the importance of roles and routines, and the environment (Meadows, 2011; Rovner, Casten, 
Hegel, Hauck, & Tasman, 2007; Warrian, Spaeth, Lankaranian, Lopes, & Steinmann, 2009). 
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People are also likely to have different patterns of impairment based on the combination of the 
various eye functions and structures affected by glaucoma which affects function differently 
(Black et al., 2011; Eichenbaum, 2012; Kotecha, O’Leary, Melmoth, Grant, & Crabb, 2009; Lovie-
Kitchin et al., 1990; Merigan & Maunsell, 1993; Milner & Goodale, 1995; Patino et al., 2010; 
Turano et al., 2004). We contend that participation may be less influenced by the variety of these 
factors since it is a unidimensional measure of what people are or are not able to do and, therefore, 
should be included in vision research. 
Vision loss is a major determinant of poorer VSQoL but ocular surface discomfort, 
psychosocial factors, and social constraints also contribute to disease burden. The clinical 
measures of visual function (e.g., visual acuity, contrast sensitivity, visual fields) facilitate the 
monitoring of disease severity but do not capture the perceived or actual effect of eye conditions 
on the accomplishment of people’s daily living situations. Participation, on the other hand, is a 
direct measure of function and disability to evaluate the effect of glaucoma on people’s 
accomplishment of social life situations. 
4.4.3 Conclusion  
While a majority of vision science research has focused on QoL as a primary outcome, few studies 
included a distinct measure of participation as a potential determinant of disability and disease 
severity for people with visual impairment or glaucoma. Rehabilitation specialists evaluate how 
vision loss affects individuals’ abilities to accomplish daily life situations they want to or need to 
do using participation. The outcomes of the evaluations serve as the basis for intervention 
strategies. Therefore, it is important that we understand how glaucoma affects participation. 
Currently, there is little scientific data in regard to participation of individuals with glaucoma while 
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there is extensive research in regard to how VSQoL is affected by glaucoma. The results of this 
study provided a unique perspective of participation to influence the care of people with glaucoma. 
This study was novel in that we provided evidence that both participation accomplishment 
and satisfaction with participation were independent incremental indicators of severity of 
glaucoma, when controlling for VSQoL, and these participation measures and VSQoL had similar 
associations with severity of glaucoma. This finding supports that participation as an outcome in 
vision research contributes to our understanding of the effects of glaucoma on daily living. 
Rehabilitation specialists who receive a referral to provide service to people with a condition other 
than vision loss need to be aware that vision loss can affect participation, especially since vision 
loss is often a hidden disability. Many people with vision loss can still accomplish their daily living 
tasks, roles, and routines that they need to or want to do. However, they may begin to change the 
frequency or the methods to accomplish such tasks which may be potential indicators of risk for 
disability and/or indicator of early disease.  
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5.0  CONCLUSION 
People with glaucoma often experience changes in their abilities to engage in social life situations 
and change how they accomplish daily living tasks, roles, and routines that they want to or need 
to do. As a result of the effects of glaucoma on their function, psychological burden often increases 
along with a fear of blindness. While historically the effects of glaucoma on people’s daily living 
were measured by people’s perceptions of their health and well-being (vision-specific quality of 
life [VSQoL]), their abilities to participate in social life situations as influenced by glaucoma has 
not been frequently measured in research and is an essential missing component to the overall 
understanding of the life experiences of people with glaucoma.  
 We explored the concept of participation because it is the immediate focus for vision 
rehabilitation goals and interventions to maximize people’s use of their remaining vision. Although 
it is important to consider the conceptual differences between participation and VSQoL, we can’t 
ignore that participation is correlated with quality of life (QoL), likely because QoL is a 
multidimensional construct. Therefore, VSQoL measures can be helpful in studying participation. 
This research study sought to explore participation in individuals with glaucoma to better 
understand the relationship between severity of vision loss related to the disease process and the 
degree to which participation was associated with severity of glaucoma.  
5.1 SPECIFIC AIMS 
This project had three specific aims: 
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1. To explore the association between participation and severity of glaucoma, 
2. To explore the relationship between participation and VSQoL, and 
3. To compare the relationship between participation and VSQoL as they each related 
to severity of glaucoma.  
5.2 SUMMARY OF FINDINGS 
To address these aims, Chapter 2 described the theoretical framework used to define the major 
constructs for this study (i.e., QoL and participation) and the current state of the science for vision 
research, including the evaluation of vision loss and its effects on function and disability. A review 
of the scientific literature indicated that VSQoL was the primary outcome measure used in vision 
research to describe the experiences of people with glaucoma in regard to the situations that most 
and/or least affected their health and well-being because of severity of vision loss related to 
glaucoma. Although clinically participation is measured in vision rehabilitation to evaluate the 
effects of glaucoma on function and disability, the focus on participation in vision research has 
only recently emerged. A limitation to existing research is that there is no consensus as to the best 
conceptualization of participation or how to best measure it.  
Chapter 3 addressed the first specific aim of this study by exploring participation of 
individuals with glaucoma. It is well documented that participation decreases with normal aging, 
yet we do not know how participation may change relative to the progression of glaucoma and 
how that differs from normal aging. We explored participation from three perspectives: frequency 
of participation, participation accomplishment, and satisfaction with participation. We found that 
for individuals who on average had early stage glaucoma, participation accomplishment (the level 
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of difficulty to accomplish a social situation and whether or not assistance was required to 
accomplish a social situation) was a statistically significant and independent incremental indicator 
of severity of glaucoma after controlling for other covariates. Exploratory analyses revealed that 
frequency of participation was more strongly correlated to socio-demographic variables (having 
the opportunity and resources to engage in participation situations) while participation 
accomplishment and satisfaction with participation were more strongly correlated to clinical 
measures of vision. These results support that participation is an important measure of function 
and disability; further study should explore the sensitivity of changes in participation over time to 
identify whether or not people with glaucoma may be at risk for vision-related disability (having 
restrictions in participation but not the lack of independence). 
Chapter 4 addressed Aims 2 and 3 for this study by exploring the relationship between 
participation and VSQoL and comparing the relationship between participation and VSQoL as 
they each related to severity of glaucoma. This chapter expanded on the findings from Chapter 3 
which described participation patterns of individuals who on average had early stage glaucoma. 
We found that participation accomplishment, satisfaction with participation, and VSQoL each had 
a similar association with severity of glaucoma when controlling for covariates. Also, each 
aforementioned measure was a statistically significant and independent incremental indicator of 
severity of glaucoma after controlling for covariates. Frequency of participation was not an 
indicator of severity of glaucoma. Additionally, the findings support that participation is a separate 
and meaningful construct from VSQoL. Given that participation is a clinical measure used directly 
in vision rehabilitation to evaluate the effects of glaucoma on function and disability and the 
effectiveness of interventions for each individual patient, we suggest that further exploration of 
114 
participation may elucidate whether or not participation can be a measure to identify people who 
may be at risk for disability because of their vision loss. 
Overall, these findings suggest that participation accomplishment, satisfaction with 
participation, and VSQoL are related. At the same time, participation accomplishment and 
satisfaction with participation contributed uniquely as incremental indicators of severity of 
glaucoma which, after further study, may inform public health awareness for the prevention of 
visual disability. Given that people with glaucoma are at risk for lower participation than people 
without glaucoma, examining their participation patterns as well as exploring the factors that lead 
to these patterns becomes critical. 
5.3 SIGNIFICANCE 
The prevalence of glaucoma increasingly affects a larger portion of the adult and older adult 
populations in the United States as the Baby Boomer generation ages and the economic impact of 
vision problems on individuals, caregivers, and non-healthcare related services will continue to 
grow. Closing the gap between people’s perceptions of their experiences and members of the eye 
care teams’ perceptions of patients’ experiences is a priority; failing to recognize this gap we 
provide suboptimal care. The care process for the medical management of glaucoma is early 
diagnosis and treatment to minimize the progression of glaucoma and irreversible visual loss that 
results from damage to the structure and function of the eye. Clinical measures of visual 
impairment facilitate the monitoring of disease severity but do not capture the perceived or actual 
effect of eye conditions on people’s accomplishment of their daily tasks, roles, and routines. In 
vision rehabilitation, on the other hand, participation is directly measured to evaluate the effect of 
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eye conditions on people’s accomplishment of life situations. As the goals of medical management 
and vision rehabilitation continue to shift towards client-centered care and prevention of disability 
by early recognition of the causes of disease and disability, understanding participation in people 
with vision loss becomes increasingly important and participation may be a potential method of 
identifying early vision loss. The findings of this study contribute to the current vision science 
literature that participation is an independent indicator of and is associated with severity of 
glaucoma and is a measure distinctly separate from VSQoL.  
5.4 LIMITATIONS 
There are several limitations to the conduct and results of this study. The design was cross-
sectional which did not include any comparisons of participation of age-matched people without 
glaucoma or without a visual impairment. While the design is appropriate to the exploratory aims 
of this study, it does not allow for study of changes in vision related to glaucoma and participation 
that may occur over time. We can make no inference as to whether or not there is a pattern of 
participation change relative to deterioration in the structure and/or function of the eye captured 
by clinical measures of vision. 
Overall, our participants had on average early stage glaucoma and high participation 
scores. The modest correlations found in this study between participation and glaucoma severity 
may be attributed to the restricted range of glaucoma severity of our sample which did not reflect 
the full spectrum of glaucoma severity in the population. In regard to the average participation 
scores, without norms for comparison it is difficult to comment on whether the compensatory 
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methods used by our participants are normal or indicators of decline. Our data merely describe 
associations between participation and severity of glaucoma. 
The dependent variable for this study was a measure of visual fields for severity of 
glaucoma. There are other components of vision, such as contrast sensitivity, that are affected by 
glaucoma for which we did not measure for our data collection nor could we control for their 
effects in our analyses. Additionally, with some measures such as the Glaucoma Symptom Scale, 
people who have no usable vision in one eye may respond to questions indicating that a symptom 
or problem is not present in that specific eye (because they have no vision in their eye) the same 
as people with intact vision and no symptoms or problems. 
The assessment instruments used in this study relied heavily on self-report. Since all the 
questionnaires were subjective measures, they carry with them several limitations. Bias is 
introduced by participants’ knowledge of their disease, the clinical significance of the differences 
in self-report scores is unclear, and life situations that are not accomplished or given up may not 
be adequately classified in terms of the inability to engage in a social situation versus desire to no 
longer engage in the social situation.  
Volunteer bias is a limitation to consider as those people who tend to voluntarily participate 
in research studies who receive no compensation may possess different characteristics than people 
who elect not to participate in research. Additionally, the method of our recruitment may have a 
bias in regard to which of the University of Pittsburgh Medical Center Eye Center(s) and which 
physicians who are glaucoma specialists for which we targeted our recruitment procedures. 
It is recognized that people with similar disease states such as glaucoma may rate the effects 
of the disease on their QoL differently since subjective measures can be influenced by factors such 
as people’s emotional well-being, social relationships, and financial constraints. In addition, 
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people who rate their QoL similarly may differ in how satisfied they are with how they are able to 
accomplish social situations. The strengths of the self-report questionnaires include capture of 
participants’ perceptions of their lived experiences and they are simple to administer and complete.  
We recognize that our study results are likely influenced by measurement error due to the 
presence of distorting influences on our assessments (e.g., errors in participant self-recording 
responses, reliability, participants’ personal distractions or clinical situational distractions). 
Measurement error is uncorrelated with the true scores of our assessment and treated as random 
error. When independent variables are measured with distorting influences, the estimates of our 
regression coefficients and their standard errors for each independent variable are biased. One 
method to address measurement error for future study is to perform reliability testing on the 
assessment instruments with larger samples of people who have glaucoma. Estimates of reliability 
based on small samples will often be too high or too low and may produce estimates of correlations 
between true scores that are inaccurate. Choosing the most reliable measure of a construct will 
minimize bias due to measurement error. The ambiguity among the constructs used in this study 
increases our risk for bias. Using multiple methods to measure a single construct is another strategy 
to address measurement error. When designing future studies, an a prioi statistical plan to adjust 
for measurement error would include structural equation modeling. 
A unique contribution of this research to vision science is its focus on participation, though 
the measurement of this construct is still early in its development. Most instruments that measure 
participation are self-report measures versus performance-based, objective measures. The 
difficulty for an objective measure of participation is developing an instrument that is specific to 
the conceptualization that participation occurs in a social environment with or for other people. 
Designing an instrument that unidimensionally captures participation is challenged by the 
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standardization of social environments that are true-to-life; such environments are often not the 
typical research or clinical setting.  
5.5 FUTURE RESEARCH 
Participation is an evolving measure in vision rehabilitation and how to best measure participation 
is still in a developmental stage. Participation is an ambiguous construct for which there is little 
consensus in regard to its measurement or conceptualization and the majority of existing 
participation instruments are self-report. Future research should continue to evolve self-report 
measures of participation and distinguishing the construct from that of activities or other 
constructs, yet research should also develop objective measures of participation given the 
limitations of self-report instruments previously discussed.  
Participation in people with glaucoma should be further explored in a sample that reflects 
a more even distribution of severity across the spectrum of the disease (i.e., later stages of 
glaucoma). Given that a majority of our participants were in the early stage of glaucoma, further 
analyses of this data set could explore whether dichotomizing the sample by age and/or severity 
would result in delineation of different types of patterns of participation. Additionally, further 
exploration is warranted as to whether or not the location of visual field loss (i.e., superior versus 
inferior visual field and peripheral versus central visual field) had any differentiating effects on 
participation. Increasingly, there is research designed to study the effects of visual field loss on 
effective visual search to locate near objects which demonstrated slower search times for people 
who had glaucoma versus age-similar controls who had no vision loss (Smith, Crabb, & Garway‐
Heath, 2011). 
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As discussed in Chapters 3 and 4, participation may be an indicator to identify whether or 
not people may be at risk for visual disability and this relationship warrants further investigation. 
Describing disability in people with glaucoma may improve earlier evaluation, diagnosis, and 
intervention. By exploring participation in people without glaucoma or without visual impairment, 
comparing their participation to people with glaucoma across the spectrum of the disease severity, 
and incorporating longitudinal data of participation, a better understanding of participation patterns 
will help inform the standard of care for glaucoma prevention and management. Once participation 
is better understood for people with vision loss, we can better research effective interventions that 
directly target successful engagement in social life situations.  
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APPENDIX A 
SIMILARITIES AND DIFFERENCES BETWEEN CONCEPTUAL MODELS OF 
QUALITY OF LIFE AND PARTICIPATION 
 
Figure 6. Similarities and differences between conceptual models of quality of life (World Health 
Organization Quality of Life Group, 1993) and participation (World Health Organization, 2001). 
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APPENDIX B 
OUTCOME ASSESSMENT EXEMPLARS 
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B.1 ELECTRONIC MEDICAL RECORD REVIEW CHECKLIST 
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B.2 DEMOGRAPHIC QUESTIONNAIRE 
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B.3 PARTICIPATION ASSESSMENT WITH RECOMBINED TOOLS-OBJECTIVE 
B.3.1 Exemplar Questions 
 In a typical week, how many days do you get out of your house and go somewhere? It 
could be anywhere-it doesn’t have to be anyplace “special.” 
Response Options: 
0 None 
1 1-2 days 
2 3-4 days 
3 5-6 days 
4 7 days 
 
 In a typical month, how many times do you do volunteer work? 
Response Options: 
0 None 
1 One time 
2 Two times 
3 Three times 
4 Four times 
5 Five or more times 
 
 In a typical month, how many times do you attend sports events in person, as a spectator? 
Response Options: 
6 None 
7 One time 
8 Two times 
9 Three times 
10 Four times 
11 Five or more times 
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B.4 ASSESSMENT OF LIFE HABITS, VERSION 3.1 
B.4.1 Exemplar Areas of Life Habits 
Employment 
 Holding a paid job 
 Taking part in unpaid activities (volunteering) 
 Getting to your principal place of occupation (work, school, volunteer center, etc.) 
 Entering and moving around in your principal place of occupation (work, school, 
volunteer center, etc.) 
Recreation  
 Participating in sports or recreational activities (walking, sports, games, etc.) 
 Participating in artistic, cultural or craft activities (music, dance, woodworking, etc.) 
 Going to sporting events (hockey, baseball, etc.) 
 Using your neighborhood recreational services (library, municipal recreational center, 
etc.) 
 
Note. From “Assessment of Life Habits: General short form,” by P. Fougeyrollas and L. Noreau, 
2003. Copyright 2005 by INDCP. Reprinted with permission. 
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B.5 VISUAL FUNCTION QUESTIONNAIRE-25 
B.5.1 Exemplar Questions  
In general, would you say your overall health is: 
1 Good 
2 Very good 
3 Good 
4 Fair 
5 Poor 
 
At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, 
if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? 
1 Excellent 
2 Good 
3 Fair 
4 Poor 
5 Very poor 
6 Completely blind 
 
How much of the time do you worry about your eyesight? 
1 None of the time 
2 A little of the time 
3 Some of the time 
4 Most of the time 
5 All of the time 
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APPENDIX C 
CHECKING THE ASSUMPTIONS OF THE DATA AND DATA TRANSFORMATIONS 
C.1 NORMAL DISTRIBUTION OF THE DEPENDENT VARIABLE: MEAN 
DEVIATION OF THE BETTER-SEEING EYE 
C.1.1  Before Transformation 
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C.1.2 After Transformation 
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C.2 HOMOSCEDASTICITY OF THE RESIDUALS OF DEPENDENT VARIABLE: 
MEAN DEVIATION OF THE BETTER-SEEING EYE 
C.2.1 Before Transformation 
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C.2.2 After Transformation 
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APPENDIX D 
COMPARISON OF PARTICIPANT DEMOGRAPHICS TO ALLEGHENY COUNTY, 
PA DEMOGRAPHICS 
Table 22. Comparison of Participant Demographics to Allegheny 
County, PA Demographics 
 Frequency (%) 
Participant characteristic This study Allegheny County 
Gender (female) 67 51.9 
Race   
Asian 3 3.2 
Black or African American 19 13.3 
Caucasian 78 81.3 
Other  2 1.9 
Not Hispanic or Latino 99 98.2 
Education (secondary or higher) 99 92.6 
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APPENDIX E 
GLAUCOMA SYMPTOM SCALE  
Table 23. Participants’ Scores for Glaucoma Symptoms of the Better and Worse-Seeing Eye 
 Better-seeing eye  Worse-seeing eye 
   95% CI    95% CI 
Symptoms M SD LL UL  M SD LL UL 
Burning, smarting, stinging 77.8 30.3 71.4 84.2  75.0 31.3 68.4 81.6 
Tearing 84.0 24.8 78.8 89.2  78.7 30.7 72.2 85.1 
Dryness 71.1 32.4 64.2 77.9  65.7 34.8 58.4 73.1 
Itching 76.4 28.5 70.4 82.4  73.9 31.7 67.2 80.6 
Soreness, tiredness 77.3 29.6 71.0 83.5  75.6 32.0 68.8 82.3 
Blurry/dim vision 73.6 33.8 66.5 80.7  68.3 33.9 61.1 75.4 
Feeling of something in 
your eye 
82.6 28.1 76.7 88.5  76.7 30.6 70.2 83.1 
Hard to see in daylight 84.6 27.3 78.8 90.3  80.3 29.5 74.1 86.6 
Hard to see in dark places 71.3 34.2 64.1 78.6  65.5 34.6 58.1 72.7 
Halos around lights 82.3 30.9 75.8 88.8  82.0 29.7 75.8 88.3 
          
Composite score 78.1 19.3 74.0 82.2  74.2 21.0 69.7 78.6 
Note. LL = lower limit; UL = upper limit. 
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APPENDIX F 
SUMMARY PARTICIPATION ASSESSMENT SCORES 
F.1 PARTICIPATION ASSESSEMENT WITH RECOMBINED TOOLS-OBJECTIVE 
Table 24. Participants’ Subscale Scores for the Participation 
Assessment with Recombined Tools-Objective 
Subscale  M SD n 
Productivity 1.37 0.52 89 
Social relations 2.18 0.83 89 
Out-and-about in the community 2.37 0.63 89 
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F.2 ASSESSMENT OF LIFE HABITS 
Table 25. Participants’ Domain Scores for the Assessment of Life Habits 
 Participation 
accomplishment 
Satisfaction with 
participation 
 
Domain of life habit M SD M SD n 
Responsibilities      
Recognize/use correct value of money 8.56 0.89 4.66 0.62 89 
Use bank card/automatic teller machine 8.41 0.93 4.58 0.73 78 
Make purchases 8.34 1.07 4.53 0.74 89 
Plan/execute budget 8.36 0.86 4.47 0.79 88 
Assume responsibilities towards others and society 8.70 0.46 4.72 0.56 89 
Personal or familial 8.72 0.56 4.62 0.73 89 
Child education 8.88 0.34   16 
Child care 8.80 0.41 4.93 0.26 15 
Interpersonal relationships      
Partner 8.84 0.45 4.74 0.54 62 
Children 8.78 0.51 4.75 0.60 73 
Parents 8.76 0.56 4.53 0.62 17 
Other family members 8.63 1.11 4.56 0.78 84 
Friendships 8.83 0.41 4.66 0.62 89 
Other individuals 8.72 0.77 4.61 0.71 87 
Intimacy  8.79 0.59 4.63 0.84 57 
Employment      
Choose a career 8.13 2.30 4.60 1.06 15 
Seek employment 6.64 3.04 3.91 1.38 11 
Maintain job 7.46 2.72 4.33 1.10 46 
Unpaid activities 8.27 1.35 4.42 0.90 55 
Get to place of occupation 8.51 0.77 4.54 0.83 61 
Enter place of occupation 8.57 0.62 4.58 0.72 60 
Use services at place of occupation 8.49 0.66 4.64 0.61 47 
Homemaking  8.41 0.81 4.43 0.79 54 
Recreation      
Sports (participant) 7.69 2.07 4.04 1.11 77 
Art, culture, crafts (participant) 8.10 1.40 4.41 0.97 58 
Sports (spectator) 7.80 2.04 4.20 1.20 46 
Art, culture (spectator) 8.14 1.60 4.43 0.89 72 
Tourist activities 7.75 2.01 4.16 1.10 75 
Outdoor activities 7.77 2.11 4.23 1.15 43 
Neighborhood recreational services 8.03 1.86 4.38 0.93 61 
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APPENDIX G 
BIVARIATE CORRELATION ANALYSIS 
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Table 26. Bivariate Correlation Analysis (Spearman rho) between Covariate, Participation, and Vision-
Specific Quality of Life Variables 
  1 2 3 4 5 6 7 8 9 
1 
MD 1.00 -.13 -.13 -.04 -.01 .10 -.09 .05 -.09*** 
2 
Age -.13 1.00 .10 .17 .11 .04 .22* -.05 -.04 
3 Length 
of dx 
-.013 .10 1.00 -.13 .08 -.03 .01 .14 .06 
4 Co-
morbid 
-.04 .17 -.13 1.00 .32** -.10 .07 -.11 .01 
5 Hearing 
disorder 
-.01 .11 .08 .32** 1.00 .12 .03 .13 -.04 
6 
Race .10 .04 -.03 -.10 .12 1.00 -.23* .38*** -.14 
7 Marital 
status 
-.09 .22* .01 .07 .03 -.23* 1.00 -.45*** .00 
8 Annual 
income 
.05 -.05 .14 -.11 .13 .38*** -.45 1.00 -.04 
9 
BCVA -.39*** -.04 .06 .01 -.04 -14 .00 -.04 1.00 
10 
GSS .36*** .04 .08 -.14 -.04 -.12 .09 .02 -.29** 
11 
Gender .28** .03 -.31** .00 -.23* -.08 .19 -.12 -.04 
12 
PHQ-9 .07 -.14 -.25* .15 .01 .05 .11 -.29** -.06 
13 
PART-O .17 .03 -.01 -.09 -.06 .35*** .48*** -.33** -.16 
14 LIFE-H 
accomp 
.28** .08 -.08 -.04 -.22* -.05 -.06 .21 -.28** 
15 LIFE-H 
sat 
.25* .01 -.15 -.17 -.14 -.08 -.10 .25 -.28** 
16 
VFQ-25 .48*** .09 .04 -.10 -.08 .03 -.06 .25* -.39*** 
Note. MD = mean deviation of the better-seeing eye; dx = diagnosis; Comorbid = comorbidities; BCVA = 
best-corrected visual acuity of the better-seeing eye; GSS = Glaucoma Symptom Scale (glaucoma 
symptoms); PHQ-9 = Patient Health Questionnaire-9 (depressive symptoms); PART-O = Participation 
Assessment with Recombined Tools-Objective; LIFE-H accomp = Assessment of Life Habits participation 
accomplishment; LIFE-H sat = Assessment of Life Habits satisfaction with participation; VFQ-25 = Visual 
Function Questionnaire-25 (vision-specific quality of life). 
*p ≤ .05. **p ≤ .01. ***p ≤ .001. 
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Table 26 (continued) 
  10 11 12 13 14 15 16 
1 MD .36*** .28** .07 .17 .28** .25* .48*** 
2 Age .04 .03 -.14 .03 .08 .01 .09 
3 
Length 
of dx 
.08 -.31** -.25* -.01 -.08 -.15 .04 
4 
Co-
morbid 
-14 .00 .15 -.09 -.04 -.17 -.10 
5 
Hearing 
disorder 
-.04 .23* .01 -.06 -.22* -.14 -.08 
6 Race -.12 -.08 .05 .35*** -.05 -.08 .03 
7 
Marital 
status 
.09 .19 .11 -.33** -.06 -.10 -.06 
8 
Annual 
income 
.02 -.12 -.29** .48*** .25** .21 .25* 
9 BCVA -.29** -.04 -.05 -.16 -.28** -.28** -.39*** 
10 GSS 1.00 -.09 -.35*** .03 .22* .38*** .60*** 
11 Gender -.09 1.00 .11 .04 .12 .12 .12 
12 PHQ-9 -.355*** .11 1.00 -.21* -.26* -.46*** -.35*** 
13 PART-O .03 .04 -.21* 1.00 .22* .16 .17 
14 
LIFE-H 
accomp 
.22* .12 -.26* .22* 1.00 .60*** .58*** 
15 
LIFE-H 
sat 
.38*** .17 -.46*** .16 .60*** 1.00 .62*** 
16 VFQ-25 .60*** .12 -.35*** .17 .58*** .62*** 1.00 
Note. MD = mean deviation of the better-seeing eye; dx = diagnosis; Comorbid = comorbidities; 
BCVA = best-corrected visual acuity of the better-seeing eye; GSS = Glaucoma Symptom Scale 
(glaucoma symptoms); PHQ-9 = Patient Health Questionnaire-9 (depressive symptoms); PART-O = 
Participation Assessment with Recombined Tools-Objective; LIFE-H accomp = Assessment of Life 
Habits participation accomplishment; LIFE-H sat = Assessment of Life Habits satisfaction with 
participation; VFQ-25 = Visual Function Questionnaire-25 (vision-specific quality of life). 
*p ≤ .05. **p ≤ .01. ***p ≤ .001. 
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APPENDIX H 
H.1 COMPARISON MULTIPLE REGRESSION ANALYSIS MODELS WITH 
COVARIATE, PARTICIPATION, AND VISION-SPECIFIC QUALITY OF LIFE 
(INDEPENDENT VARIABLES) FOR INDICATORS OF SEVERITY OF GLAUCOMA 
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Table 27. Multiple Regression Analysis Models with Covariates, Participation, and Vision-Specific Quality of Life (Independent Variables) for 
Indicators of Severity of Glaucoma  
 Model 1 Model 2 Model 3 Model 4 Model 5 
Variables ?̂? R2 
Adj 
R2 ?̂? R2 
Adj 
R2 ∆R2 ?̂? R2 
Adj 
R2 ∆R2 ?̂? R2 
Adj 
R2 ∆R2 ?̂? R2 
Adj 
R2 ∆R2 
Age, yr -.09 .30 .24 -.15 .38 .32 .08** -.17 .39 .33 .02 -.18* .47 .40 .07** -.18* .47 .40 .00 
Length of 
diagnosis, mo 
-.13   -.14    -.12    -.16 
   
-.15 
   
Number of 
comor-
biditiesa 
-.04   -.01    -.01    -.06 
   
-.05 
   
BCVA, 
logMAR 
-.28**   -.14    -.12    -.09 
   
-.09 
   
Glaucoma 
symptoms 
.29**   .14    .17     .20 
   
 .20 
   
Gender .20*   .14    .14     .18* 
   
 .18* 
   
VSQoL    .38**    .26     .43** 
   
 .43** 
   
Participation 
accomplish-
ment 
       .18     .29* 
   
 .28* 
   
Satisfaction 
with 
participation 
           -.39** 
   
-.38** 
   
Frequency of 
participation 
           
    
 .05 
   
Note. Adj = adjusted, BCVA = best-corrected visual acuity of the better-seeing eye; logMAR = logarithm of the minimal angle of resolution, VSQoL = vision-
specific quality of life.  
aNumber of comorbidities not including glaucoma. 
*p ≤ .05. **p ≤ .01. *** p ≤ .001. 
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APPENDIX I 
MEAN DEVIATION CORRELATIONS WITH PARTICIPATION AND VISION-SPECIFIC QUALITY OF LIFE 
Table 28. Correlation Analysis (Spearman rho) for Mean Deviation Scores of the Better-Seeing Eye with Participation and Vision-Specific Quality of 
Life Subscale Scores 
 Participation subscale scores 
 Productivity Social relations Out-and-about Comp score       
PART-O .10 .15 .13 .17       
 Responsibilities Interpersonal relationships Community life Employment Recreation Comp score   
LIFE-H 
accomp 
.24* .03 .20 .18 .36*** .28**   
LIFE-H 
satisfy 
.17 -.01 .14 .20 .27** .25*   
 Vision-specific quality of life subscale scores 
 
General 
health 
General 
vision 
Ocular 
pain 
Near 
vision 
Distant 
vision 
Social 
funct 
Role 
diff 
Mental 
health 
Depen-
dency Driving 
Periph
vision 
Color 
vision 
Comp 
score 
VFQ-25 .10 .48*** .23* .46*** .38*** .35*** .43*** .42*** .41*** .15 .35*** .34*** .48*** 
Note. PART-O = Participation Assessment with Recombined Tools-Objective (frequency of participation); LIFE-H accomp = Assessment of Life Habits 
participation accomplishment; LIFE-H satisf = Assessment of Life Habits satisfaction with participation; VSQoL = vision-specific quality of life; VFQ-25 =  
Visual Function Questionnaire-25; Comp = composite; funct = functioning; diff = difficulties; Periph = peripheral. 
*p ≤ .05. **p ≤ .01. ***p ≤ .001. 
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